• H&R Moderators: VerbalTruist | cdin | Lil'LinaptkSix

News TRAUMA | MDMA passes big test for PTSD treatment ->

1-teens.jpg



Teens who are bullied struggle with long-term mental health issues

by Jared Wadley | University of Michigan | 24 Mar 2020

Bullying can make life miserable in the short term for teens, but its impact can also linger into young adulthood, says a University of Michigan researcher.

Much is known about the negative effects of bullying, ranging from depression to poor performance in school, but a new study indicates that bullied teens can suffer long-term mental health problems that last into early adulthood.

How these individuals perceive themselves contributes to these outcomes, said study author Janette Norrington, U-M doctoral student in sociology. The study, which appears in the journal Youth & Society, also indicates that verbal abuse and peer harassment are more harmful than physical victimization or social exclusion.

Previous research has shown that youths suffer short-term mental health consequences, but less is known about the negative, long-term impact between the ages 18 to 24.

Norrington used longitudinal data from the Panel Study of Income Dynamics to examine teen self concept as a mediator in the relationship between adolescent peer victimization and psychological distress in emerging adulthood.

Self-concept, which is the image people have of themselves or self worth, is a link between teen bully victimization and later mental health. Bullying includes physically harming, making fun of, excluding, and spreading rumors about a person.

"Bully victimization damages how people view themselves in adolescence and that negative view can linger into adulthood, contributing to poor mental health," she said.

Norrington examined the responses of more than 1,400 adolescents in 2002 and 2007, who were questioned about the frequency that classmates hit them and picked on them, had their things (money and lunch) taken and were left out of friends' activities. In 2009 and 2013, as adults, they were asked how often in the past month they felt nervous, hopeless, sad and worthless.

Peer victimization is still associated with higher levels of psychological distress, but the impact is lessened among those with high self-esteem, the study found.

"Intervention and mental health programs should focus on enhancing the self-concept of adolescent bully victims," Norrington said. "One way to do this would be to emphasize peer support to help youth feel valued and develop self-confidence."

"In addition, adult mental health programs can also address former bully victims' self-concept and help them process their past peer victimizations to improve their mental health,"
she said.

 
Last edited:
The-Ibogaine-Conversation-pt1-plant.jpg



Iboga found to resolve and heal childhood trauma*

by Dylan Charles | Reality Sandwich | March 1, 2018

Imagine being able to go back in time to relive those experiences from your childhood which have had the greatest impact on your life. Imagine being able to witness yourself as a child, but from the perspective of yourself today, looking at traumatic events with the understanding and compassion of an adult.

On the cutting edge of mental wellness is the exploration of the effects of childhood trauma on the long-term health of human beings. Dr. Robert Block, former President of the American Academy of pediatrics remarked, “adverse childhood experiences are the single greatest unaddressed public health threat facing our nation today.”

American pediatrician Nadine Burke Harris looks at how exposure to adversity and trauma during their developmental years leads to mental health diagnoses such as ADHD, anxiety and depression. She points out the negative effects of trauma on the developing brain and immune systems of children, as well as how traumatic events can develop into chronic stress, and even PTSD.

Her viewpoint that health issues can be rooted in adverse childhood experiences (ACE) runs counter to the popular understanding of illness, which presumes strictly material causality and dismisses intangible psychological factors. A 1990’s study on ACE, however, demonstrates significant corollaries between trauma and lifelong health, linking them to illnesses and high-risk and impulsive behaviors such as drug addiction.

"Adverse childhood experiences underlie many health problems. As researchers followed participants over time, they discovered that a person’s cumulative ACEs score has a strong relationship to numerous health, social, and behavioral problems throughout their lifespan, including substance use disorders. Furthermore, many problems related to ACEs tend to be comorbid (co-occurring with a primary disease or disorder)."

Counseling, psychotherapy and even prescription psychotropic medications may be used to help people resolve traumatic experiences, but some view this type of healing as an issue of spiritual health. Dr. Gabor Mate looks at severe drug addiction as the result of childhood trauma, treating some patients with the ceremonial use of Ayahuasca.

Approaching trauma with the use of psychedelic plant medicines can be quite effective, and the African plant medicine iboga is uniquely powerful in this regard. Ingestion of this sacred medicine is known to induce a powerful and visionary psychological experience which allow the participant to review and relive key moments of their past.

"Iboga is a psychoactive plant medicine derived from the root bark of the Iboga tree, found in certain parts of Africa. It is administered ceremonially in rites of passage and healing ceremonies tended to by master shaman who have successfully negotiated the spiritual realms into which the medicine plunges its participants. It is known for its power to bring a person into direct contact with the realms of the deceased, and also for allowing a person to see deeply into their past in a way that permits open communication with themselves as they were in the past. The psychoactive journey typically lasts for up to 36 hours and dramatically detoxifies the physical body, as well as the psycho-spiritual body."

Remarking on how iboga assists patients with sever PTSD, Gary Cook of Iboga Wellness in Costa Rica said:

"People that have gone through the iboga process to work on their PTSD describe the experience as comparable to 10 years of therapy compacted into a week. Iboga gives you a chance to go deep. It not only helps with detoxing the body, but the mind as well. As long as the person is open and willing to work on themselves, iboga is a powerful tool. Many people have said that it gave them a chance to relive a traumatic event from an observer’s point of view. During a retreat they were able to forgive and move on, experiencing closure for the first time. Also, it gave their body a chance to detox from anti-depressants that they have tried with no success. Every person has a unique life, therefore every person has a unique journey."

The journey itself is an adventure through the timeless realms of consciousness and the cosmos, looking at the entire library of information about one’s life, and making corrections and connections to rewrite the present by re-integrating the past and understanding the future.

I commented on this experience in a 2014 article entitled Opiates, Iboga and the Roots of Self-Destruction:

“…the shaman will guide the patient in iboga journeys, opening up an introspective experience where a connection is made with an over-soul or cosmic consciousness that assists the mind in a deep examination of the self from an objective, omniscient and timeless perspective. In this, a process unfolds which unravels one’s past, offering life-changing insights and liberation from accumulated self-judgments and harmful thought patterns."

"For 12-24 hours the patient lies still, with blindfolded eyes, in a dream-like state where the brain behaves as if in REM sleep, but while the conscious mind remains awake, very alert and able to interact with and direct the content of the mental journey."

"As the experience deepens, the barrier between the conscious and sub-conscious mind seems to dissolve, and the information in the sub-conscious mind becomes available for review and rejection by the reflective self. During this experience, a lifetime’s worth of memories, emotional impressions, false judgments and psychological conditioning that combine to inform and instruct the self are presented to the patient in rapid fire fashion… a high velocity behind-the-scenes tour of one’s personality. A new impression of one’s character emerges, and they are given an incredible opportunity to re-assess or reject misunderstood feelings, traumatic events, negative self-images, and habitual behaviors.”
~Dylan Charles

While the term adverse childhood experiences typically refers to severe physical or sexual abuse and/or emotional neglect, often, seemingly less significant events can also cause a lifetime of problems.

As an example, I like to tell the story of a friend who was able to overcome 54 years of emotional turmoil in one night during a powerful iboga journey. Going into the ceremony, she set the intention of working to understand why she had always had night terrors and high anxiety over an event which happened when she was less than two years-old.

For her entire life, she was carrying around the terrorizing imprint of this shocking event, which had all this time remained incomplete in her mind, leaving her confused and resentful. All she could remember was being stuck in a crib, screaming for help, as her mother and aunt came and went in a frenzy, totally ignoring her.

During her journey, she asked to relive this moment, and she did so, but from the perspective of herself as an adult, having a better understanding of human behavior and dramatic situations. Seeing herself in the crib in startling clarity, she was able to explore this event, and she discovered that this terrible memory was of the day her father had a heart attack.

She was able to see her father, collapsed in the hallway outside of her room, as her mother and aunt worked frantically with the medical crew to ensure his survival. Until this moment, she had never before understood why she felt so scared, confused and ignored,

Iboga gave her the ability to see what had really happened, and she was able to instantly forgive her family and herself of any enduring blame or guilt about the traumatic event. In the morning she was a brand new person, with a light and bright smile on her face. It was a life-changing and liberating realization for her.

Final thoughts

The efficacy of psychedelic plant medicines in treating the root causes of trauma, addiction, disease and behavioral disorders is being demonstrated by a growing body of research and experiential evidence. And as more and more personal accounts of such journeys are presented online, we inch closer to an integration of these medicines into the contemporary scientific worldview.

*From the article here :
http://realitysandwich.com/322702/h...-iboga-can-resolve-and-heal-childhood-trauma/
 
Last edited:
dontshoot-575.jpg



Childhood trauma in the U.S. is a public health crisis

by John Schmid | Milwaukee Journal Sentinel | 21 Nov 2019

If American children grew up in homes without abuse, alcoholism, mental illness, drugs or domestic partner violence, instances of depression in the general population would fall 44%.

If such a world of trauma-free households could ever exist, national unemployment would fall 15%. There would be 24% fewer heavy drinkers and 33% fewer smokers. Cases of coronary heart disease — the leading cause of death in the U.S. — would fall 13%.

Those are among the findings in a new study that has special relevance to Milwaukee and Wisconsin, regions that already have been studying the impact of nonmilitary psychological trauma on their populations.

Issued by the U.S. Centers for Disease Control and Prevention, the study ranks as the most comprehensive examination to date on the lifelong impact of adverse childhood experiences, known as ACE’s.

ACE’s measure exposure to potentially traumatic events before age 18, including physical, emotional or sexual abuse. ACE research remains an emerging science but consistently shows that neurological trauma inflicted in childhood often is the root cause later in life for chronic stress and anxiety, opioid addiction, sleep disorders, unemployment, homelessness, suicide and other post-traumatic disorders.

From 2015 to 2017, the CDC surveyed 144,000 Americans in 25 states, including Wisconsin, making the sample more than eight times bigger than any previous ACE study.

Tia Richardson coaches volunteers on how to paint details of the "Sherman Park Rising" mural, a reaction to a disturbance in the summer of 2016 in the neighborhood. The City of Milwaukee Arts Board named Richardson one of its 2018 Artists of the Year.

The psychological scars of trauma are invisible and often cloaked in stigma. But the new data lays bare the breadth of a national epidemic of domestic trauma. About one in six Americans (16 percent) admitted to four or more types of potentially traumatic experiences as they grew up, landing them in the high-risk category of those most prone to mental and physical health afflictions, according to the CDC report.

No ethnicity or geography is immune, the data shows, meaning trauma can affect those caught in farm foreclosures in rural Wisconsin as well as suburban homes where an alcoholic breadwinner loses his job. As a share of the population, the CDC found that 15% of white adults admitted to four or more ACE's. That compares with 16% for Hispanic adults, 18% for African American adults and 28% for Native Americans.

In Milwaukee in recent years, ACE studies and trauma research have shifted the understanding of chronic social and economic problems. Regional leaders are rethinking how to address the region’s most chronic problems, including school dropouts, incarceration, addiction and human sex trafficking.

"The study validates the strategy of SaintA, a large Milwaukee-based social services agency that's active across the state, to align its efforts around trauma-responsive practices and interventions," said SaintA chief executive Ann Leinfelder Grove.

"We are doing what the science tells us," Grove said. She's making the CDC study required reading for her board of directors ahead of their next meeting.

For the last two years, the Milwaukee Journal Sentinel has published a series of multimedia stories, called A Time to Heal, which documents communities of concentrated trauma in rural Wisconsin communities as well as urban areas like Milwaukee and Racine.

The scale of Milwaukee's trauma-driven social dysfunction overwhelms the existing agencies and nonprofits. SaintA is active in new collaborative efforts to coordinate the region's disparate trauma-responsive initiatives among social service workers, therapists, university researchers, leaders of nonprofits, criminal justice authorities and health care representatives.

"There are good things happening in Milwaukee, but this report can compel us to continue the push," Grove said.

The CDC's methodology was simple. It asked eight blunt yes-or-no questions: Before the age of 18, were you abused, either physically, emotionally or sexually? It asked about five other kinds of household adversity: adults who abused drugs or alcohol; adults who were incarcerated; adults with mental illness; parental divorce; or witnessing intimate partner violence.

The same respondents also were asked a separate roster of questions: Do you suffer from coronary heart disease, cancer, diabetes? Are you overweight? Depressed? Did you finish high school? Are you unemployed?

The results "grossly undercount" the severity of widespread trauma and its impact on physical and mental health, said Melissa Merrick, lead author on the CDC study.

In an interview, Merrick explained that respondents routinely withhold information that involves deeply personal and painful events. "To even get to one-in-six (who admit to high-risk exposure) on a state-level random-dial telephone survey means the real numbers are way higher," said Merrick, adding: "It's just a fact."

Even so, compared with someone with zero “yes” answers, a person with four or more ACE's is more than five times more likely to suffer depression and more than three times more likely to smoke. The high-risk four-plus category is nearly twice as likely to have coronary heart disease. There’d be far less obesity and fewer high-school drop outs.

Like almost all ACE studies, the CDC survey has shortcomings. Whether a traumatic event such as sexual abuse happens once or repeatedly, it only counts as a single ACE score. The CDC questions ask what happened in the home and exclude experiences at school or on the streets. It doesn't count emotional neglect, which can be particularly toxic. Nor does it try to measure the effects of racism.

The CDC study is the most comprehensive and most recent, but it's not the first. A project funded by the National Institute of Justice, the research arm of the U.S. Department of Justice, studied the life histories of every mass shooter in the United States dating back to 1966. "The vast majority of mass shooters in our study experienced early childhood trauma and exposure to violence at a young age," it found.

"Childhood trauma too often is fatal," said Merrick. Citing other studies, Merrick said ACE's have been linked to at least five of the top 10 leading causes of death, including heart disease, cancer, respiratory diseases, diabetes and suicide.

“Exposure to ACE’s is one of the biggest public health crises we confront in this country,” Merrick said.

 
Last edited:
BAgeorgesarlo0710-standingW3.jpg



Profound psychedelic journeys brought peace to this Holocaust survivor

by Alix Wall | July 16, 2020

After his father disappeared to a forced labor camp in 1942, when George Sarlo was just 4 years old, it left a traumatic wound that would not heal for the next 70 years.

Then, when he was in his 70s, Sarlo had a life-changing experience. After ingesting a psychedelic native plant in a Mexican fishing village, Sarlo says he had an encounter with his dead father, who finally provided an answer to the question that had plagued his son for so many years: why he’d left without saying goodbye.

That experience eight years ago has today made Sarlo, a successful San Francisco venture capitalist and philanthropist, an unlikely advocate for the use of psychedelic drugs to treat trauma, addiction, and the fear and anxiety that can accompany a diagnosis of terminal illness.

Sarlo, 82, shared his story last November at Congregation Emanu-El, explaining how his father leaving without saying goodbye had haunted him for 70 years — nearly his entire life. Many of those listening were brought to tears.

Born in 1938 in Budapest, Sarlo was one of two children; his sister was seven years older. When the Hungarian government began passing anti-Jewish laws, Sarlo’s father lost his job as a clerk in a textile mill. Friends allowed him to buy remnants of fabric from the mill, and he and Sarlo’s mother, a talented seamstress, began sewing women’s lingerie that his father would sell to dealers. They earned a decent living, until his father had to report for deportation to a labor camp. He left early one morning and never returned.

For the next three years the family moved around, living in fear and dread that the Nazis could deport them — something that happened to their entire extended family, none of whom survived.

To make sure the same did not happen to her small family, Sarlo’s sister risked her life, sneaking out of the house to the Spanish Consulate, where she obtained lifesaving documents. Issued Spanish passports and papers, they spent the last three months of the war in a Budapest apartment with some two dozen others under the official protection of the Spanish government. Sarlo calls his sister “the hero of the family.”

When the war ended, Sarlo remembers a box arriving with warm clothing, Hershey’s chocolate and chewing gum. It came from the Joint Distribution Committee.

“My mother could not believe that somebody who didn’t even know us sent us all this,” said Sarlo. “The idea of philanthropy was never explained to us.” Being the beneficiary of such philanthropy at a pivotal point in his life would have great influence years later, when he was in the position to give back himself.

After liberation, Sarlo’s family stayed in Hungary and Sarlo entered the Technical University of Budapest in 1956, the year of the short-lived Hungarian revolution against Soviet control. Sarlo took part in the conflict, putting himself and his family in danger. His mother advised him to flee the country with his sister, his sister’s husband and their 2-year-old son. She had remarried another survivor and they would stay in Hungary.

“It’s the bravest thing I’ve ever heard. She said ‘Go,’” he said.

Sarlo carried his 2-year-old nephew during much of the escape. His backpack and a scarf from his mother that he wore while sneaking through a minefield and around electric-charged fences are now in an exhibit on refugees at the Smithsonian Museum.

They made it to Vienna, where they hired someone to smuggle Sarlo’s mother and husband out of Hungary, and eventually the whole family made it to America, where they were received by the Hebrew Immigrant Aid Society. Sarlo was 18, and the very next day he was working as a draftsman at an engineering firm.

Sarlo’s trajectory is a real immigrant success story. He attended the University of Arizona on a full scholarship and then went to Harvard Business School. He made his first million dollars within three years, working on Wall Street. He was a founder of the first venture capital firm investing in Silicon Valley and in 1973 founded his own firm, Walden Venture Capital.

“It was good timing. My whole life was good timing,” he said.

His first foray into philanthropy was with the International Refugee Committee, as Sarlo identified strongly with the plight of refugees, having been one himself. He also remembered the JDC box his family received in Hungary, and he eventually joined its board as well.

"There are some difficult times coming, and I’m not even sure that the species can survive without some change."

For many years Sarlo remained distant from his Judaism, but the connections began to build.

In the early 1990s, he accepted an invitation from local philanthropist Warren Hellman to join a Torah study group.

In 1992, he founded the George Sarlo Foundation and asked Phyllis Cook, then endowment director of the Jewish Community Endowment Fund at the S.F.-based Jewish Community Federation, to sit on his board. In time, she asked him to start a fund with the Federation.

The George Sarlo Foundation primarily funds mental health initiatives, with a major focus on addiction and early childhood trauma. Another focus, on psychedelics, brought Sarlo some notoriety after he was featured in an article in the New York Times last fall talking about funding research of psilocybin and MDMA. Given his own experiences, he has come to believe that even one guided experience with psychedelics as an adult can heal trauma or PTSD.

It was that 2012 trip to Mexico that convinced him of the healing power of psychedelics. At the recommendation of a fellow Hungarian Holocaust survivor and therapist friend, Sarlo went there specifically to take ayahuasca, a plant-medicine commonly used for rituals and healing by Indigenous people in Peru and other South American countries.

It was not a decision he made easily — “You want me to go where and do what?” was his first response. But his friend, who had been using psychedelic therapy to treat addiction and trauma, made a persuasive argument.

In the second of two “journeys” with the substance, which is taken in a sacred ceremony led by a shaman, Sarlo says he had a conversation with his long-dead father, who told him that the reason he didn’t say goodbye was because he thought he was clever enough to get out of any situation, and that he’d return home by the time his son woke up.

“It’s a simple explanation and it fit,” said Sarlo. “Slowly, the low-grade depression I had experienced for most of my life lifted and never came back. And I decided I wanted to help give this incredible gift to as many people as I can manage.”

Sarlo credits psychedelics with more than curing his depression. They also played a role in bringing him back to his Judaism.

During another psychedelic exploration, this time on psilocybin mushrooms, he had what he describes as a confrontation with God. In this particular vision, he saw God as male (though he’s seen her as female too). God asked Sarlo why he had turned away, and Sarlo pointed to the Holocaust and the loss of his extended family.

“The greatest gift I gave to humanity is free will,” he says God told him. “But then along comes Hitler. What was I supposed to do? Drown him? What about the runaway car about to hit a child? Am I supposed to save them all? You can’t have it both ways.”

“Now that’s an explanation I had heard before, but it didn’t register,”
Sarlo said. “This time, it registered.”

Sarlo married and divorced twice and had two daughters. Neither wife was Jewish; he believes he subconsciously chose to marry non-Jewish women so his children wouldn’t be Jewish and therefore would be safe — though of course in the Holocaust that wouldn’t have mattered.

In the end, both of his daughters married Jewish men. Two of his grandchildren had b’nai mitzvahs and the third had a Jewish rite-of-passage ceremony.

“It’s hilarious, because it shows God has a sense of humor,” is how Sarlo explains it.

“George Sarlo had experienced this big healing within himself, a tikkun,” said Rabbi Sydney Mintz, who moderated the conversation last fall at Emanu-El. “He could have just done this and thought ‘It’s my own thing and I’m healed,’ and that would have been acceptable, but he wants to share this with people; it’s transformed him into a teacher.”

Sarlo has been working on a book to be published this summer with MAPS, the Santa Cruz-based Multidisciplinary Association for Psychedelic Studies, but the pandemic and the presidency of Donald Trump has made him feel a level of fear he had hoped never to feel again, he said. He’s now revising the original manuscript.

“There are some difficult times coming,” he said, “and I’m not even sure that the species can survive without some change.”

But he seems to have found peace within himself. “I think that because of my experiences, both in Judaism and with psychedelics, I’m a much better father,” he said. “I’m a much better grandfather and better friend. And I’m better to myself.”

 
Last edited:
mdma.jpg



Using psychedelics to heal from sexual trauma

by Sophie Saint Thomas | DoubleBlind | 29 Jan 2020

Psychedelics are promising tools to help survivors reprocess their experience and heal from PTSD.

Psychiatrists diagnosed me with so many different conditions after I was sexually assaulted that I don’t remember them all. What was wrong with me? Suggestions included generalized anxiety disorder, insomnia, ADD, panic disorder, and depression. It turned out that I had PTSD, which is an insidious monster with many arms that do indeed manifest as everything from insomnia to flashbacks to depression. What I really wish is that someone had told me: “You were raped. That's awful, and life is going to be a bit harder now. But you are strong, and you will be okay.”

While I took SSRIs and went to therapy, my first memory of real healing was through cannabis. It took away nasty flashbacks getting in the way of my sex life. But while cannabis currently may be the most mainstream medicine in the psychedelic community, it’s far from the only one helping sexual assault survivors heal from trauma.

“I think that psychedelics can be used as tools to help people access greater embodiment and safety around reprocessing their trauma and, in the words of sex therapist and psychedelic integration therapist Dee Dee Goldpaugh, experiencing a ‘compassionate recasting’ of ourselves in the story,” says activist Leia Friedman, host of The Psychedologist: Consciousness Positive Radio. “MDMA is probably the most commonly used medicine for treating sexual trauma, but I have heard from different people that ayahuasca, psilocybin, ketamine, LSD, and mescaline-containing cacti were all helpful, as well.”

Years after my assault, when that asshole, depression—a side effect of PTSD—showed up again, I began Ketamine intravenous therapy, which has been shown to help both PTSD and treatment-resistant depression. It worked better than anything I had ever tried.

For those like Alexandra Evers, 30, psilocybin intervened. The Detroit-based graphic designer had been in an emotionally, physically, sexually and financially abusive relationship for six years. Against her abuser’s wishes and behind his back, she took shrooms with her best friend. “It was a transformative experience for me, and I believe I would be dead today if I hadn’t gone through with it,” Evers says of that first trip. “I was able to step outside of myself. I saw my life from a wholly different point of view that my inhibitions and denial hadn’t allowed me to see.” Later, alone in her apartment, a realization hit Evers: “I was suddenly overcome with the knowledge that he would kill me. It was a shining moment of perfect clarity that I had never experienced before and haven’t since. I knew that he would murder me if I didn’t pack up and leave. So I left.”

Evers’ experience demonstrates the unique power of psychedelics to provide a lightning bolt of realization. “Psychedelics like mushrooms help you access a shift in self-consciousness,” says Michelle Janikian, author of Your Psilocybin Mushroom Companion: An Informative, Easy-to-Use Guide to Understanding Magic Mushrooms. Evers survived the abusive relationship she was in, but her departure from it was not uneventful. “Two months later my abuser shot himself in the head with a shotgun in that apartment,” she says. “I know that if I had been there, he would have killed me too. I am absolutely sure of it.” Today, Evers continues to use psilocybin on her own with people she trusts to guide her through working on her trauma.

Perhaps a reaction to such a cruel violation, perhaps because survivors who come forward are often called liars, but it’s beyond normal to blame yourself after sexual assault or abuse. Psychedelics, however, may be uniquely poised to treat PTSD stemming from sexual abuse because they help the survivor step outside their traumatized minds and see themselves compassionately. Ketamine works behind the scenes, restoring structure and anatomy, stimulating the dendritic and synaptic growth that was disrupted through childhood trauma. You experience relief about ten hours after the IV infusion (in my experience, a dissociative high is mostly a pleasant side effect), other medicines treat trauma through the trip itself.

“Using the psychedelic psilocybin and the empathogen MDMA can both create psychic spaces within individuals to gain a deeper sense of self,” says psychologist and sexologist Dr. Denise Renye. “MDMA can help an individual recollect a sexual assault without the PTSD symptoms of freeze, flight or flight. MDMA can also allow for the survivor to have a sense of empathy for their self that went through the assault, thus alleviating some of the self-judgement that sometimes accompanies it.”

Research shows that PTSD causes changes in the hippocampus, amygdala, and medial prefrontal cortex, which leads to alterations in memory. Psychedelics can help survivors see their experience the same way we’d view an assault that happened to our best friend—with compassion rather than self-blame.

Of course, there is one glaring, deplorable elephant in the room: Most psychedelics are illegal. While this doesn’t prevent survivors from obtaining them, it does make it tricky to do so in conjunction with therapy. “Integration is greatly important. This can be done with a therapist who understands the healing potential of plant medicines and empathogens,” Renye says.

Integration, as the name suggests, refers to integrating wisdom learned from a psychedelic experience into your day-to-day life. It’s wonderful to feel deeply compassionate to yourself during a trip, but speaking therapeutically, it doesn’t matter much if that feeling isn’t harnessed, nor those lessons maintained. “If proper integration is not done mindfully, it will just be a trip and the journey aspect of it will be lost,” Renye says. “It is a journey from feeling broken to experiencing one’s self as whole.” Proper integration, she adds, can be done with a therapist one-on-one, or in a group setting.

"Integration is an ongoing process that may include meditation, conscious body movement, mindful walking in nature, and sound healing," Renye says. She also recommends keeping a journal after the journey, as it might be easy to forget the transformations that occurred.

Cities such as Oakland and Denver are decriminalizing psilocybin, and researchers are conducting trials on MDMA, ketamine, and more for PTSD treatment. The future looks hopeful but we—survivors of sexual assault—have a long road ahead of us. For now, if you’re a survivor considering psychedelics, remember how important setting and integration are. “I do not advise recreational use for the purposes of healing a sexual trauma,” Renye says. “I also do not advise doing this sort of experience without the guidance of someone who is trusted and trained. If set and setting are not taken into consideration, there is potential for a deeper level of trauma to occur.”

At the very least, it’s a good idea to have a trusted friend with you to act as a “sitter.” “Before the journey, talk with the sitter about ways to ask for support, such as physical contact like a hand to hold or a shoulder to lean on,” says Leia Friedman. “It’s important to also discuss how to stop physical contact both verbally and non-verbally, and both people must agree that there will be no sexual contact during the session.” Some professionals warn against using psychedelics for trauma without the aid of a trained therapist, because there is a risk of opening old wounds.

I can’t emphasize enough the relief I felt after I found ketamine. It was as if I had been swimming in choppy waters (and acting like it) and suddenly I could stand calmly on land. “How the hell, did I not know this option existed earlier?” I thought over and over. I continued to see a therapist and take my SSRIs, but psychedelic medicine provided a massive change. If you’re a survivor reading this story, until you find your medicine, let me remind you: It’s not your fault.

 
Last edited:
How psychedelics freed me from childhood trauma and taught me to accept my past

reset.me | May 28 2019

Putting the pieces together. May love be with you.

I grew up in a small village in the eastern countryside of Germany. Around the age of five, my father started to sexually abuse me. My mother, struggling with borderline syndrome, was neither able to protect nor rescue me.

Even though my mom knew about the sexual abuse, she would call me a liar, penalize and threaten me. To my mom I was the ugly, bad and unwanted child, while my sister became her second man in command to support my banishment.

These circumstances created a situation where my father was the only person I could in some way rely on as a child. He became the only person that would give me in some way the feeling of love and acceptance. At the same time, this created a symbiosis between us where he crossed all borders and abused me sexually until the age of 12. I was never allowed to show any feelings and always under the pressure to function as perfect as possible. There was not much love, just judgment, anxiety and punishment.

I divided and concurred myself, created a robot-version of myself and lived an awake dream, purely to survive – deeply believing I have a perfect family and grew up in the best circumstances and have the best parents. Not remembering a day of my childhood before I turned 12.

Many years later, I escaped of a very abusive and consumptive relationship, finding myself in the middle of a deep manic-depression with a desire to just die. I was only sleeping a couple of hours per night, working 15 or more hours per day, drinking lots and lots of alcohol, experiencing panic attacks a few times per day and severely depressed. I was very close to committing suicide but still had a tiny small inner belief that there must be help somewhere.

The next two years I sought help through behavior oriented therapy until much later I found out that I was suffering from a Post Traumatic Stress Disorder (PTSD). The behavior therapy was an extremely important first step back into life and helped me to survive and get myself organized on a healthy schedule. Even so, I was still suffering from all my PTSD symptoms: panic, anxiety, eating disorders, unstable relationships, depressions, dissociations, all kinds of physical pain, nightmares, paranoia, a life outside of my body. To cut it short, it felt like a wild roller-coaster ride through hell that would never stop.

One year later I felt ready, to dig deeper into my past and joined a trauma therapy program, mostly working with EMDR, hypnotherapy and IADC. All of this work helped me a lot of work, understand what a trauma is and what my trauma in particular is about, why I am having panic attacks, what is triggering me, why I struggle so much with healthy relationships, how I can access my feelings and how to cry and to trust.

All of this was extremely important groundwork, guiding me to that day, where I read “Miss America by day” from Marilyn Van Derbur. This shifted my mindset and for the first time I could see how all my different battles I was fighting tie into a bigger in a bigger picture. I could “feel,” in the bigger scheme of things, why I was reacting the way I did and why I was so all over the place. I was so splintered, like a broken mirror. Still, it was not possible for me to feel myself. I started to understand and to remember but I could not access any feelings or my body.

In the meantime, I met the most wonderful, strongest and loving human being on earth, who became my partner and my best friend. He not only showed me what unconditional love is about, but also helped me on every step on my journey to heal. He also introduced me to the fascinating world of therapeutic psychedelic treatment.

After doing lots of research and not getting further in my therapy, I found psilocybin as a possible next step to open my inner door. I felt that all my feelings were stashed, deep down under a blanket of cement and I would need an atomic bomb to open this door. I started with a first test trip on magic mushrooms. Light dose, more to explore myself, the effect and also my reaction to it. The mushroom treated me well. I got shaken a bit and felt this might be a good door opener.

The second journey I took on 5grams of magic mushrooms at home, in bed, with closed eyes and headphones. I wanted to travel deep inside of myself. So far, so good, but there was one thing I hadn’t reckoned with. I am a perfect runner and hider. My inner SWAT team is trained to do whatever needs to be done to not allow me to connect with my feelings. What happened is that, I more or less passed out or dissociated. I “woke up” after three hours not remembering much and being truly convinced the trip was over. I learned that in the future I need a trip-sitter, who sits with me and is holding me back from escaping.

The next trip I planned was out in the nature together with my trip-sitter. It started in a little hut and ended with a walk at night, in nature. Heading out at night, in the dark back then was one of the scariest things I could imagine doing.

I took magic mushrooms (psilocybin), sat down and started to meditate. Every time I was on my way to escape, he would carefully hold me back. It was amazing! I transformed into sound and explored my body the first time without pain and discovered my feet.

I was able to connect to my inner child at the age of five. It brought me back to all of the wonderful feelings of my true-self and helped to realize who I am. The luggage that resulted was from my trauma. It gave me so much energy to continue my journey back to my true self and it also gave me the hope that I am so much more than just a broken mirror. It opened a door that I would have never been able to open without this magic treatment.

I continued my psychotherapy for another year and learned that working with trauma needs a lot of different strokes; meditation, a good therapist, safe home, art therapy, somatic body experience and love only to name a few.

Over time it became more and more clear that I was suffering the most from anxiety. Many, many years later after the incidents of my childhood, I was still not able to fully touch the ground because my anxiety was so deeply planted in me that I just couldn’t get through it. By the time, I discovered the wonderful work of psychotherapist Friedericke Meckel, learning that MDMA can be used to let go of anxiety.

I started my first journey with MDMA on 100 micrograms at home after a very adventurous day, with guitar music and a cozy blanket. I did not explore a trip in that sense, but all my anxiety was blown away and the first time in my life I could relieve my feelings. I could just cry it all out, for hours, without panic or anything else. Really just let it go. For me, knowing only a life in deep anxiety and the constant fear of punishment and dying, this was mind-blowing relief. A state whereI could never have imagined to getting to.

After this deep and healing experience, I went on two a second MDMA journey, but this time with a higher dose of 150 micrograms. I went out to the nature and found myself in high fascination for the world and deep inner peace. This experience really helped my body and my inner control team, to understand that it s ok, to let go and that I can survive without anxiety. A few days after this trip, I experienced a deep inner healing. It was as if all the pieces of the puzzle could now connect back together. I was finally able to reconnect to my old feelings. Feeling how it was to be abused for me as a child, not be loved, not be protected and never to be safe. And, it was ok – no panic. For people like me, with a heavy panic disorder, this opens a whole new world! I was able to feel myself and also my old feelings.

My third trip on MDMA (all with some weeks in between) was in a club. I had the intention to feel it out in public and have a good time. But, it surprised me again in a very different way than before. It struck me from the back and I felt for the first time that I missed my Mom. With all the hate, anger, disappointment and pain there was never room for the little girl just poorly missing her mommy.

Now I could feel deeply, how much I missed her and how sad I am that I in a way never had a mom. Also that as an adult women I needed to figure out everything myself without having someone (carrying the wisdom of womanhood) to be with me. I had never been able to cut the cord because the little girl in me was missing her so so much and still hoping that one day she would accept me as her daughter, just the way I am. It was there, for the first time that I could accept this as being part of me.

One year after my last magic mushroom trip, I went on to my annual winter-forest-hut-vacation. I had experimented in the last months with micro-dosing and explored some interesting outcomes. Mushroom micro-dosing helped me in daily life to stay in my body, made me braver but also more humble in the bigger scheme of the universe. Even so, I was not sure if I was ready for another full journey. There is this funny thing with mushrooms, the less you want them the more important it is that you take them. So I went on a 6 gram mushroom journey, in the valley of love, somewhere in a Polish nature reservation park. It blew me away.

The preparation with MDMA and helping me to understand my anxiety but also to not run away anymore made it an incredible experience. When I was at the peak, I looked into the deepest, darkest, dirtiest shit I was carrying with me. The stuff I usually avoid, I cannot. I must except it as part of myself even though it scares me so much that I start to run. I sat, in the eye of a thunderstorm, without body, just pure feelings and saw all the darkness.

I survived it. It is in me and that’s ok too. It felt as if the universe sucked me, chewed on me, puked me out into another universe and beamed me to a frozen hell. It feels like I was born anew in that night, finally landing on planet earth as one whole person. Thank God for my trip-sitter. I was later also able to explore the other side of yin-yang. I recalled happy memories, deep feelings from and for my mom. The feeling of her warm skin on my baby skin, her smell, her body and me being close to her. The feeling of her rubbing down my back after a bath. I came back to the point where I still had a mom. Not for long and not steady, but I had had a mom. I’ve experienced this unique love. And I am so thankful that I had the chance to feel it again and bring it with me to the present.

A mushroom journey is never an easy one – there is always darkness that comes with the light, there is always a yin to the yang. But, it helps so much to not only see the world in black and white.

I’ve always been split in many pieces and could barely accept my own story or my own past. It has always been one of the biggest battles to keep the good separated from the bad. The mushrooms (and MDMA) helped me to see myself fully as one person and also to allow myself to be this person and forgive myself. Traumatized people have the tendency to only see good or bad and nothing in between. On the journey of healing it is important to put both pieces together. Finally, I “felt” as though I am no longer alone, the stars will always be with me.

 
Last edited:
cptr-event-2018-banner.jpg



Treating the effects of trauma with cannabis

Michelle Thiessen and Sarah Daniels | CHACRUNA

We are all impacted by experiencing or witnessing traumatic events such as violence, accidents, and the death of loved ones. As we struggle to find ways to deal with the symptoms that can persist in the aftermath of experiencing trauma, cannabis is increasingly being hailed as a potential solution. Nearly 90% of adults in the USA have experienced a traumatic event severe enough to meet criteria for post-traumatic stress disorder (PTSD). Of those of us who experience such a trauma, nearly 10% go on to develop full-fledged PTSD, a disorder that involves difficulty recovering from the traumatic event, and includes feeling irritable and jumpy, avoiding reminders of the trauma, intrusive memories, nightmares, insomnia, anxiety, and a pervasive sense of doom. In some cases, people may even feel as if the traumatic events are happening again. The symptoms of PTSD are severe on their own but are often made worse as sufferers may withdraw from family and friends, engage in problematic substance use, and experience suicidal impulses. Sadly, a sizeable portion of people who have PTSD do not respond to frontline treatments such as medication and psychotherapy. Due to the severity of PTSD, and the lack of effective treatment for many of those who suffer, the potential for cannabis to treat PTSD has been met with much hope and enthusiasm. Although we are not yet at the point where we can decisively say that cannabis is helpful for treating PTSD, research that can help answer this question is underway. As we wait for further results, a number of interesting findings have led scientists to believe that cannabis may help some people who struggle with the aftermath of trauma. In this article, we will take a look at some of the science behind the claims that cannabis can help treat PTSD.

People with PTSD using more cannabis

One way of understanding whether cannabis might help with PTSD is to examine naturally occurring cannabis use among people with PTSD. Surveys clearly show that individuals living with PTSD are more likely to use cannabis than those without the disorder. The behavior of people with PTSD involves efforts to cope with the disorder, and as such, elevated rates of cannabis use may suggest that these people feel that cannabis is helping to relieve their PTSD symptoms. Veterans are more likely than the general public to experience a traumatic event due to the nature of their work, and report using cannabis to help deal with the after effects of military-related PTSD. One survey found that more than half of veterans surveyed reported using cannabis, and one in ten said they used cannabis specifically to relieve symptoms caused by their trauma. Another study of veterans found that those experiencing less symptom recovery from traditional therapies were more likely to use cannabis, and that higher levels of PTSD symptoms are associated with more cannabis use, which may suggest that cannabis is being used to treat more persistent symptoms. Individuals with PTSD also report using cannabis to help with PTSD symptoms such as problems with sleep and mood. Taken together with the many informal reports from organizations that support people with PTSD in using cannabis therapies, the use of cannabis by people with PTSD suggests that cannabis therapies deserve careful examination as potential PTSD treatments.

Cannabinoids and PTSD: Evidence from inside and outside the human body

The cannabinoids most of us are most familiar with are the molecules produced by the cannabis plant, such as THC and CBD. However, our bodies are also equipped with a specialized system that produces its own cannabinoids. That system is called the endocannabinoid system, and it helps to regulate things like sleep, appetite, and our ability to handle stress. Differences in the endocannabinoid system that are associated with PTSD symptoms can help us to understand how plant-based cannabinoids might help with PTSD. While it is not clear whether a disruption in the endocannabinoid system is a result, cause, or combination of both with regard to PTSD symptoms, people who develop PTSD after experiencing a traumatic event have been found to have differences in their endocannabinoid systems compared to those who experience similar events but don’t develop PTSD. For example, an important study of individuals who were in New York during the 9/11 attacks found that those who went on to develop symptoms of PTSD had lower levels of the body’s self-made cannabinoid, anandamide, in comparison to those who did not develop PTSD. Interestingly, anandamide resembles the THC found in herbal cannabis, which suggests that using external cannabinoids like THC may help to supplement the body’s own internal cannabis system.

What do studies with animals tell us about cannabis and PTSD?

Animals also possess an endocannabinoid system and have their own ways of responding to trauma and stress. Studies of cannabis and stress in animals can provide some clues as to how cannabis use may impact stress response and learning in humans. After exposure to trauma, animals exhibit symptoms similar to those seen in PTSD, such as an amplified startle response and an impaired ability to unlearn conditioned fear responses. Previous studies have found that giving a cannabinoid to animals after exposing them to trauma can relieve these symptoms.

How does cannabis help with PTSD?

One of the key ways that cannabis may help people with PTSD is by improving sleep. Cannabis use can impact dreaming, and among those with PTSD, it may help to reduce the frequent and disturbing nightmares that are among the most distressing symptoms of the disorder. A study of incarcerated men found that nearly three-quarters of inmates with PTSD who took an oral capsule of THC had their nightmares reduce or stop entirely. Reducing nightmares may be particularly important for improving the quality of life of people with PTSD, as better sleep can help to equip people to deal more effectively with other stressors, and may help them be more active in treatment, and with family and friends. In addition to improving sleep and decreasing nightmares, cannabis may help those with PTSD by more generally reducing anxiety and improving mood. However, regular cannabis use can also lead to withdrawal symptoms when cannabis use stops. Symptoms of cannabis withdrawal can include irritability, anxiety, and nightmares. Because symptoms such as these may already be problems for people with PTSD, starting and then stopping cannabis use might ultimately make PTSD worse rather than better. Helping people with PTSD who use cannabis manage their use and potential withdrawal is an important challenge that may play a big role in determining if and how cannabis medicines can be effective treatments for PTSD.

Active studies and the future of research on cannabis and PTSD

Clinical trials are an important method of establishing the effectiveness of a treatment, and completing such clinical trials will be necessary before cannabis can become a recognized treatment for PTSD. There are currently two clinical trials underway in Canada and the United States that, together, will include almost 200 participants with chronic, treatment-resistant PTSD. Both are double-blinded studies using a crossover design and different CBD/THC ratios of cannabis, including a placebo containing only a trace amount of THC. Neither the researchers nor the participants know what potency they are receiving. Both studies also have a six-month follow-up after the active participation has concluded. It is hoped that results from these trials will be available by 2020, if not sooner. Although these results may go a long way toward telling us how cannabis might be helpful for treating PTSD, information from other sources, such as following people with PTSD who use cannabis over the long term, and examining different types of cannabis—and different types of PTSD—will also be needed to help us understand how this complex plant might play a role in treating this complex disorder. Given the prevalence of PTSD, and the lack of effective treatment for many who suffer, such research is very much warranted, particularly in light of preliminary evidence that suggests that cannabis may help with some of the most troublesome symptoms of PTSD.

 
Last edited:
images



The role of trauma in treating addiction

by The Fix | 15 Oct 2020

People who have suffered trauma often need to address its lasting effects before they can get a handle on their substance use.

The word trauma is used today more than it ever was ten years ago. While some people might feel like the word is overused, many mental health professionals would say that we’ve just become better at recognizing the lasting impact that events — from losses to abuse — can have on our psyches.

Many people with substance use disorder have trauma in their backgrounds. Trauma causes residual lasting mental pain. If you don’t address the trauma, you might find yourself self-medicating to escape the mental pain. Although that might work for a moment, using drugs or alcohol to cover your mental pain will just cause more difficulties in the long run. That’s why it’s so important to find a treatment center that understands the interplay of trauma and addiction.

Understanding trauma

The American Psychological Association (APA) defines trauma as an emotional response to a terrible event. What constitutes a terrible event varies from person-to-person. An event that is traumatic for one individual might not cause trauma for other people, even if they experience the very same event. Anything from abuse to a natural disaster to an accident can cause trauma.

It’s normal to experience some psychological distress after a major event. Consider the stress that we all experienced early on during the pandemic. But, for most people, the stress gets better with time. If you find that your stress continues to interfere with your life, you might have trauma. Symptoms of trauma can include flashbacks, headaches and nausea.

Sometimes, trauma can evolve into post-traumatic stress disorder (PTSD). PTSD is characterized by lasting effects of trauma that impacts life. People with PTSD might have flashbacks or nightmares; they might avoid certain situations that remind them of the traumatic event.

The connection between trauma and addiction

There’s a close connection between trauma and addiction. A 2019 study compared people who were getting treatment for opioid abuse disorder with healthy individuals. It found that the people in treatment reported more severe traumas and more instances of trauma in their lives. The study found that the more trauma people experienced, the more likely they were to experience addiction.

The connection can be particularly strong for people who experience trauma as teens or children. Among teens who needed addiction treatment, 70% reported trauma in their backgrounds. In addition, 59% of teens with PTSD go on to develop a substance abuse problem.

Research like the ACEs study — which looked at adverse childhood experiences — have solidified the connection between trauma and addiction. Even seemingly minor ACEs, like growing up with divorced parents, can increase the risk for substance use disorder later in life.

Treatment for trauma

If you have experienced trauma or ACEs, and particularly if you believe you may have PTSD, you need to access a recovery center that is trauma-informed. Trauma-informed treatment centers have knowledge about the ways that trauma impacts the brain. They are able to help you address your substance abuse disorder, while also helping to control your trauma.

Of course, it is also a great idea to get specific treatment to help you overcome PTSD, if you are experiencing that condition. EMDR — Eye Movement Desensitization and Reprocessing — is a type of therapy that is particularly effective for treating PTSD. During EMDR, you recall your traumatic event while doing to back-and-forth eye movements. Scientists don’t understand exactly why this is so effective at reprocessing the traumatic event, but research shows that people make huge improvements in just a few sessions.

The takeaway

Trauma is extremely common: up to 70% of American adults have experienced a traumatic event in their lives. Some people recover on their own, while the trauma lingers for others. Too often, people use drugs or alcohol to try to numb or escape the trauma.

Oftentimes, people need help to overcome trauma in their lives. Finding and utilizing a treatment center that has a trauma-informed approach to treating substance use disorder can help you understand the role that trauma plays in your addiction. Then, by addressing the underlying cause of your addiction, you’re better able to stay sober long-term.

 
Last edited:



Dissolving childhood trauma through psychedelic therapy

by Michael Causton

In this presentation, I will detail my experience of the power of psychedelic therapy in dissolving the effects of childhood trauma. While subjective, I hope to provide some useful feedback on MDMA/Psilocybin therapy for therapists and patients. Treating childhood sexual and other abuse is notoriously hard. Conventional therapies are many but treatment is, in my experience and talking to several hundred other survivors over the years, rarely more than a partial success.

In my own case, conventional therapies allowed reduction in self-blame and an increased trust in relationships. However, the level of understanding and integration remained largely intellectual with little emotional depth. As a result, the core problems of complex PTSD, depression and self-rejection remained.

MDMA and psilocybin therapy made it possible to connect in real-time with the traumatic events of the past in a safe way (not so much cinematic, more like time travel). The result was an incredible experience of emotional release and then integration. This made it possible to "return home" to myself and, over time, become whole. The crippling problems of PTSD and depression dissolved. In my case, the deep-seated effects of childhood trauma could not be treated head on but through re-integration of the whole person.This was only possible through psychedelic therapy.

Michael was born and raised in the UK and has Masters degrees in Philosophy and Japanese from Cambridge and Stirling Universities. Married with two children, his day job is running a small business research company about Japan while also trying to pursue his passion for researching and writing up best practices for recovery from childhood abuse – and the rest of the time trying to keep up, unsuccessfully, with his sons on basketball and tennis courts.

He was assaulted and abused from aged 10. He tried many forms of therapy with highly qualified clinical psychologists over a 10 year period with partial recovery. Five years later he sought help again leading to MDMA-based therapy and then psilocybin with unqualified success.

 
Last edited:
rutger-hauer-blade-runner-1.jpg



MDMA and the trauma of life threatening illnesses*

by Phil Wolfson, MD | psychedelic.support | 24 Nov 2020

Thanks to the success of modern medicine, more people are surviving life threatening illnesses (LTIs) than ever before. This also means more people are living with trauma that results from surviving these conditions. Join Dr. Phil Wolfson as he explores the results of an MDMA-assisted clinical trial for people with life threatening illnesses, and how psychedelic therapy could help treat, and even prevent, PTSD-LTI.

Modern medicine is producing a vast and rapidly increasing population of survivors of life threatening illnesses (LTIs) due to its successes. Unfortunately, for many the cost of survival may well be trauma to mind as well as body. From its difficult commencement, the impact on patients may well be harmful–with the shock and life change of diagnosis, the ensuing treatment which may well be arduous and diminishing of capacities both physical and mental, through often long term treatment, and then recovery. The nature of the traumas induced vary in depth, and symptomatology, on spirit and relationships.

Our experience with 18 subjects with life-threatening illnesses who enrolled in an MDMA-assisted clinical trial led us to the conviction that it is essential for prevention of this trauma that beginning with diagnosis of the LTI there be implementation of psychosocial strategies. Support for patients and their dear ones during the course of the illness and its medical treatment extending through the recovery period needs to be provided.

It is just not enough to focus our medical skills on interventions for illness and to leave on the sidelines the impact on the human experience. Our study delineated the breadth and variety of the traumatic reactions which we have defined as a new Post Traumatic Stress Disorder—PTSD-LTI. Delineation of the plethora of symptoms that make for this diagnosis has been described as well as criteria for diagnosis.​
…we with our subjects were able to have significant impact on their traumatic residues, their fears for relapse and death…
MAPS sponsored our unique Phase 2 study of anxiety as the primary marker for those with LTIs and a life expectancy of at least one year. Based on what may well be the most intensive psychotherapy with subjects who have trauma from life-threatening illnesses (LTI), with MDMA experiences as a fundamental part of the process, we with our subjects were able to have significant impact on their traumatic residues, their fears for relapse and death, and their struggle to make recoveries with full resumption of lives that had moved on—morphed from before their diagnosis and the sudden threat of protracted illnesses and death itself.

MDMA-assisted psychotherapy is a reciprocal process and as much as our subjects responded and changed, so did we as practitioners. In fact, we experienced profound changes in our awareness of illnesses multiplicity of manifestations, the causation and breadth of trauma and our own self concepts.

Over the course of the three years of this intensive and intense study, we experienced a progressive revelation of the traumatic nature of this diagnosis and its aftermath, and its various manifestations in cognition, motivation, affect, spirit, meaning, relationships, and view of self. Exposed to our subjects’ suffering and impacted ways of being and to their tension with potential recurrence of illness and death, we grew to be a unit for exploration and healing.

So many of our sessions were marked by strong emotions and we often experienced a unity with our subjects’ suffering and liberation from it. For the mind, heart and spirit are inseparable and the MDMA experience carries this at its center. There is joy in this work, meaning and connection that is far more possible to achieve in the long and deep sessions of MDMA work.​
MDMA-assisted psychotherapy is a reciprocal process and as much as our subjects responded and changed, so did we as practitioners.
While anxiety was our primary marker for enrollment in our program and for measuring its outcome, trauma in its impact on our subjects, was the predominant cause of the suffering they experienced. And while our focus was on the specific causation of the LTI and its aftermath, earlier trauma also was an inevitable part of the work.

We used the STAI Trait measure in conformity with other studies of psychedelic-assisted psychotherapy. But if I were to do it again, and we are in the process of preparing a ketamine-assisted psychotherapy study of LTIs, I would and will pursue using assessments of trauma as the primary measure.

In the best sense of developing clarity about suffering with LTIs (and other forms of suffering) coming to the PTSD-LTI designation continues the expansion of psychology’s reclamation of trauma to its true status as the overwhelming cause of human distress and dysfunction. Sadly, that realization remains incomplete.

Near attitudinal blindness continues to the effects of traumas to humans caused by prejudice and culturally embedded formats–such as racism, sexism, caste, and class that are forms of domination; to war; refugee displacement; poverty and to illness. That myopia remains and limits our evolving view. Prevention of trauma remains the abiding issue for developing a healthy population instead of a wounded population—as per the World Health Organization.​
Prevention of trauma remains the abiding issue for developing a healthy population instead of a wounded population.
Our view of trauma from within psychiatric diagnostic categories such as those for depression and anxiety tends to be only partially reflective of lives lived and affected by past and ongoing trauma. Focusing on limiting clusters of symptoms, diagnoses can be constraining conceptual structures that prevent clear views of the complex matrix of existence and the fullness of the expressions of suffering in their myriad aspects.

It is essential to turn to a comprehensive and phenomenological view of suffering–its prolongation beyond the intruding traumas that are immediately afflictive; an awareness of prolonged traumatization; developmental trauma; its diverse expression in diverse beings.

This enables the therapeutic conversations that give forth recognition and validation to trauma victims in need of understanding themselves and for being understood. This does and will engender the conscious connections that are healing in themselves and lead to the alleviation of suffering–to the extent we are able; and to the prospect for better caring of those who have been afflicted with traumas.​
What makes this so appealing has been the demonstration of efficacy in small Phase 2 studies with MDMA in PTSD; with psilocybin for LTIs, and now, ours, the first to test MDMA as a treatment for this indication.
While attention to the experience of those facing death from LTIs has become a more prominent part of palliative care and hospice consciousness and there have come to bear a variety of psychotherapies, it is only in recent years that it has been possible for a resumption of clinical interest in the potential for psychedelic medicines–provided in an assisted psychotherapy format-to address PTSD-LTIs.

What makes this so appealing has been the demonstration of efficacy in small Phase 2 studies with MDMA in PTSD; with psilocybin for LTIs, and now, ours, the first to test MDMA as a treatment for this indication. Prior studies with psilocybin have demonstrated the value of peak experiences on PTSD-LTIs and reduction of anxiety and depression. MDMA as less of a hallucinogen and operating through a variety of means to promote empathic connection to oneself and others, offers a different modality for psychotherapy.

With its wide variety of manifestations, the treatment of PTSD-LTI is an individualized matter. Yet, clusters of concerns emerge from personality, family, history, morality, religiosity, culture, gender, class, ethnicity and more. ‘Taking stock’ as life is threatened is one common path. So too is ‘denial’, even until the very end. So too is the great fear of cessation and non-being. As well as: who we are; who we feel ourselves to have been; peace or dissatisfaction; love or rage; or the mishmash of it all. Confusion is common to us and it comes and goes.

The compassionate non-judgmental work of being a therapist in such a crucible is many sided—moving, frustrating, loving, opening, patient, persevering, available, self-reflective, resonant, orchestrating, social working, family system conscious, and above all respectful of the differentiation of each of us. It relies on assisting in the access to each of our own desires for healing, connection, and realization.

In essence, for PTSD-LTI patients, there is a relatively specific set of treatment outcomes that are desirable and are relevant to the diagnosis. These can be clustered as follows with ratings provided subjectively:​
  • Did your experience help you with recovery from the emotional effects of being diagnosed and treated for a life-threatening illness?​
  • Do you feel more vital?​
  • Are you able to feel more pleasure?​
  • Do you have a greater sense of peace?​
  • Did your experience help you to connect and integrate with the important others in your life?​
  • Did your experience help you with your fears of death and dying?​
  • Did your experience help you think about and plan for what you consider your remaining life span?​
  • Have you been able to find and give meaning to your remaining life?​
  • Do you feel you have made peace with the possibility of having a limited future?​
  • Have you been held by or found a spiritual or religious path?​
  • Have you been helped in planning for future treatment options and for your ultimate death?​
  • Do people in your life notice a difference in you in these ways and other ways?​
While the improvements as expressed by the assessment measures used in our study certainly indicate these issues being addressed, it was in the therapeutic work with our subjects over the many days of contact in which these concerns were delineated and assistance rendered. Our study highlights the need for more sensitive measures that reflect the manifestations of PTSD-LTI and allow for assessment of the benefits of treatments for this difficult state.

It also supports the benefit of an intensive psychotherapeutic approach applied within a brief therapy context. The six-month follow-up assessment and psychotherapy session validated the continuing impact of our MDMA-assisted psychotherapy and is in contrast to the usual 8-week evaluative period for antidepressant trials. It argues for the intensity of contact between therapists and subjects as a cost-effective process.​
It argues for the intensity of contact between therapists and subjects as a cost-effective process.
MDMA-assisted psychotherapy provides a unique approach to conscious work with patients. With the prolonged sessions that last 6-8 hours, therapists are more available to patients and must present as human beings in greater fullness than in conventional work. Trained to be cautions of countertransference and working dyadically, interaction is more alive and fruitful. The therapeutic crucible is based on the reality testing that is forthcoming from this contact.

Under MDMA’s particular influence, an open mind ensues with the possibility of letting go of persistent traumatic embedded attitudes caused by the LTI impact. While MDMA is not significantly hallucinogenic, it is powerfully trance and reverie inducing.

Mind moves in both recollection and imagination and is freed from its usual constraints and inhibitions. It opens the floodgate of compassion for self and others and suffering is realized, contextualized and expressed. By reducing the alarm system’s traumatically induced hypervigilance and self-protective mechanisms, MDMA balanced with the presence of therapists and the nest that has been constructed with its down lining of the assurance of safety—unlocks the fear-shut awareness of suffering and its causes. The ensuing rush of the spring waters of healing and balancing a new gush forth.

Each person, in their particular idiosyncratic fashion, may well experience the restructuring of self and an awakening of view leading down new paths and resulting in the ripening of the fruit of new life. As if there has been an inherent internal force awaiting its liberation, its resumption of being the guide to life lived ethically and passionately, creatively and in connection.

Rarely do psychiatrists and therapists write or speak of the exhilaration of having the opportunity to work intensively with their patients. The success of our study is reflected in the deeply moving experience of working with our subjects as well as in the outcome measures.

To succeed in psychotherapy, therapists must find compassion, respect and understanding for their patients—at least to some extent. MDMA-assisted psychotherapy brought us into intimate contact with the deepest of life’s struggles. While maintaining a therapeutic stance, we also participated in the intimacy of a shared human experience that touches us all.


Evan Sola, PsyD, MDMA therapist in LTI study talks about his experiential training

MDMA-assisted psychotherapy has this particular nature to it. It does not work in this manner for everyone—no therapy is universally successful or applicable to all the ways in which humans are dilemma-d. So, as we build the psychedelic psychotherapy toolbox, our potential for administering a broader range of experiences adds to our hopeful success rate in alleviating and ameliorating suffering.

The work with psilocybin for LTIs has demonstrated its utility in providing a hallucinogenic experience that benefits those suffering with PTSD-LTI. This occurs with a different therapeutic construction that is deeply experiential in its inner liberation, and not primarily of a psycholytic nature as is the case with MDMA. The nest is built, the therapeutic relationship is supportive and the experience/experiencer interaction does the liberating rectification relying on the ‘mystical experience’ of the journey. This is the elegantly performed process initiated decades ago with mushrooms and LSD.

Ketamine-assisted psychotherapy available as presently the only legal psychedelic is of yet another nature. It can be psycholytically applied at low doses that reduce defensiveness and create access somewhat in the same vein as MDMA, or with more robust doses creating a time-out from ordinary mind, ego dissolution and access to realities of new construction.

Freed from obsessions, daily concerns and debilitating moods, the journey is liberating and on return enables a reconstruction of self and the recognition that not all is suffering, despair and inevitable. Ketamine is a profound hallucinogen which when embedded in its particular format for therapeutic work is beneficial for all sorts of human predicaments. And marijuana deserves its place and the practice of marijuana-assisted psychotherapy is growing and as it is legal now in most states can be amalgamated with ketamine or stand on its own.​

All psychedelics tend to move a person into a spaciousness of mind that is meditative in nature given our separation from constraints, usual attitudes and prejudices.
The intent of all psychedelic psychotherapies is to result in a reduction of out mental attachments and enable freedom to explore our lives without being so encumbered. All psychedelics tend to move a person into a spaciousness of mind that is meditative in nature given our separation from constraints, usual attitudes and prejudices.

Psychedelic experiences tend to enhance one’s ability to imagine, be fresh and creative. Integrated with daily practices and the active realization of our connectedness to all things and all beings, they tend to bring a person closer to each other and ourselves for lives lived in gratitude, sharing, love and community. It is up to us to realize their potential as we build our practices and learn the potentialities for the therapeutic application of psychedelic medicines.

In the psychedelic gladiator’s arena, confusion arises. A tendency to extol the virtues and superiority of one medicine over another conforms to the ‘ownership’ of the psychedelic pharma development of their uses for prescription. Money, fame, and first to the finish line motivation all create mystification.

In fact, all psychedelic medicines have potential for broad effects and broad applications. Head-to-head studies may occur but seem frivolous. The realms for the therapeutic applications of our medicines as they become available are nurtured by our understanding of our patients, their particularities, personalities and struggles and our knowledge of the best practices and the therapeutic prospects emerging form our work together. This is the best way to proceed!

*From the article here :
 
Last edited:
blog6.jpg



MDMA could revolutionize care for trauma, a social worker’s perspective

by Courtney Hutchison | Feb 19, 2019

In my role as a social worker and psychotherapist, I see so many clients suffering from the repercussions of trauma—experiences of abuse, neglect, and discrimination—that have left them struggling to feel safe on a fundamental level.

Healing from these traumas invariably focuses on helping these clients overcome feelings of disempowerment and disconnection, rebuilding interpersonal trust and intimacy in the context of the therapeutic relationship.

At the same time, there is growing recognition in the mental health field that we must address trauma across multiple levels: not only interpersonally or psychologically, but physiologically. We must also heal the way trauma inscribes itself on the brain and body, leaving survivors hijacked by nervous systems that vault into fight, flight, or freeze at a moment’s notice.

That is why it is imperative that social workers, and all mental health professionals, take notice when a new promising treatment comes along that seems to treat trauma across these multiple levels: the limited, adjunctive use of MDMA (3,4-methylenedioxymethamphetamine) in psychotherapeutic treatment for posttraumatic stress disorder (PTSD) presents just such a treatment.

MDMA-assisted therapy as a breakthrough treatment

Research on MDMA-assisted psychotherapy for PTSD has been growing over the past 15 years, showing remarkable success in clinical trials. The FDA granted it “breakthrough therapy” status in 2017 based on these strong results.

For example, a 2011 study found that 83% of those receiving a combination of supportive psychotherapy and two MDMA-assisted psychotherapy sessions no longer met criteria for a PTSD diagnosis after treatment, compared to only 25% of those who received the same supportive psychotherapy and a placebo.

Moreover, these studies were working with the hardest-to-treat cases—clients whose PTSD had failed to respond to other treatments, such as prolonged exposure therapy, other cognitive behavioral therapies, or pharmaceutical medications. Follow-up studies have shown that the majority of those helped are still PTSD-free nearly four years later.

These striking findings led me and my colleague, Dr. Sara Bressi, to explore the potential of this treatment, especially given the stigma often attached to MDMA as being the primary ingredient in the recreational drug “molly” or “ecstasy” (though substances found in recreational settings are rarely observed to be pure MDMA).

This article is a summary of the findings from our recent paper on this topic, including: why mental health professionals are in dire need of better treatment for PTSD, how MDMA-assisted psychotherapy works, and how important a treatment like this could be for addressing the immense burden of trauma in vulnerable communities, especially communities of color and low-income communities.

Treating PTSD is an uphill battle

For those with PTSD, past traumatic events intrude upon their daily life through flashbacks, nightmares, and pervasive anxiety and hyper-vigilance that makes it difficult for them to engage in day-to-day life, and can make it especially difficulty to talk about or reflect on their traumatic experiences.

In an attempt to minimize their symptoms, individuals with PTSD often avoid anything that could trigger them, and begin to isolate themselves from the world and others—consequences that tragically cut them off from the potentially healing effects of relationships, both within their personal lives and within the context of therapy.

Existing PTSD treatments try to reduce these symptoms in a few different ways: psychiatric medications try to change brain chemistry to reduce anxiety; exposure therapies try to de-link trauma triggers from the strong fear response; skills-focused therapies target areas such as emotional coping and interpersonal skills; other trauma-informed approaches try to create a sense of safety in session that rebuilds trust over time and extends outside of the therapy room.

Unfortunately, these treatments often have mixed results and do not meet the needs of all people with PTSD: studies in veterans, for example, show that more than 70% of those engaging in PTSD treatment do not see significant improvement.

How does MDMA-assisted psychotherapy work?

In MDMA-assisted psychotherapy, the MDMA acts as a catalyst for the therapeutic process, working synergistically with regular psychotherapy sessions. Biochemically, MDMA releases chemicals that increase a sense of well-being, enhance empathy and feelings of closeness to others, and dramatically reduce fear and anxiety.

A potentially key ingredient in this process is oxytocin, sometimes called the “love hormone” because we release it when we bond socially, when we are with people we care about, and even when we cuddle with our pets.

In a course of MDMA-assisted psychotherapy, traditional talk therapy is interspersed with two or three medicated sessions. These medicated sessions occur over 6-8 hours (the drug’s duration plus a few hours), under medical supervision, and consist of periods of quiet introspection and client-led discussion of traumatic material, facilitated by two therapists.

Non-drug psychotherapy sessions then help process and understand what came up for client while on the drug. After treatment, which generally occurs over 8-15 weeks, the majority of participants are not only PTSD-free, they report an “increased self-awareness,” “increased ability to feel emotions,” and “improved relationships in general.”

Though research on why MDMA is such a powerful catalyst is still new, in our paper we hypothesize that MDMA’s fear-reducing and pro-social affects work together to help clients tap into their capacity to heal, allowing them to engage in therapy faster and more profoundly than they could otherwise.

The fear-reducing effects help clients think and talk about their trauma without being as hijacked by flashbacks or panic symptoms, allowing them to gain perspective on what happened to them and integrate it into a larger narrative of their lives.

The pro-social effects help clients trust and bond with their therapists and “take in” the support and empathic attunement they provide—a task that is especially difficult for those who have had their trust violated through interpersonal trauma and abuse.

Moving forward: How this treatment could be a game-changer

That MDMA-assisted psychotherapy has worked so rapidly, and so effectively, in many people who have not responded to existing treatments is a powerful testament to its potential—especially for low-income communities and communities of color who disproportionately experience trauma.

At the same time, it is unclear what access to this treatment will be like for these populations. Given that people of color and low-income individuals already face the dual hurdle of being more likely to experience trauma, and less likely to have reliable access to health care, it will be essential that social workers be attuned to these potential barriers and be fierce advocates for access to this breakthrough treatment.

First and foremost, trauma survivors have experienced ruptures in trust—trust in others, in the safety of the world, and in their own inherent value. Too often, these ruptures are then tragically re-experienced in relationships with loved ones, clinicians, and institutions.

If MDMA-assisted psychotherapy, in helping clients move toward spaces of empathy and trust, can facilitate and accelerate repair of these ruptures, its use will have repercussions far beyond the treatment of PTSD symptoms.

It could enable clinicians to more readily, more consistently, and more profoundly tap into what psychotherapy at its best offers: a pathway toward more fully, authentically, and lovingly engaging with themselves and their lives.

https://psychedelic.support/resources/mdma-assisted-psychotherapy-trauma/
 
Last edited:
GAS_ibogaineforWBUR7_31_18x020.jpg


Ibogaine for the treatment of trauma

by David Dardashti | CISION | 9 Mar 2021

The most effective means for a person to deal with Post Traumatic Stress Disorder is to internalise and relive the events in the past. In doing so they are confronting repressed emotions associated with feeling associated with the trauma. Research suggests that Ibogaine Hydrochloride helps people gain an introspective experience of past endeavors. In doing so people are able to understand how the events in their lives have contributed to their present situation. It also suggested that Ibogaine helps with the personality defects associated with trauma by distributing a balance among cerebral hemispheres in the brain. A Clinical study done on special forces soldiers from 2015-2017 displayed a high reduction in symptoms relating to Post Traumatic Stress Disorder with the therapeutic treatment of Ibogaine.

The mind body problem suggests a conception of thought processes that can be perceived in a similar manner to a computer and its operating system. In other words, the functionality of the brain can be perceived as a concrete entity similar to hardware of a computer (For example an HP). On the other hand the mind can be perceived as the abstract software used to execute programs on a computer (E.G. Microsoft). It is essential to understand psychological complications through both a biological and neurological standpoint. One of the most difficult struggles mankind faces is post traumatic stress disorder. Ibogaine hydrochloride can help a person recover from the emotional turmoil from their past. Previous research suggests that this holistic approach will aid a person in recovery on both a neurological and psychological level.

It is essential to begin an understanding of the neurological benefits of ibogaine hydrochloride in relation to post traumatic stress disorder. Studies have shown that ibogaine influences the chemicals in the brain which influence rapid eye movement during sleep. (Maps). One of the main issues associated with trauma are night terrors. This dilemma empairs a person to enter one of the most vital sleep cycles. A cycle which is responsible for restoring a person's natural chemical makeup responsible for happiness and serenity. The ibogaine helps this process by activating systems in the emotional part of the brain, which is most active during early infancy. Aside from restoring the physical entities impaired as a result from the trauma this begins to establish a therapeutic approach to ibogaine treatment for post traumatic stress disorder.

Moving on to the therapeutic benefits of ibogaine hydrochloride in the treatment of post traumatic stress disorder. It has been suggested that the ibogaine helps a person remember the events associated with their trauma without having the emotional strain that occurred during the event (erowid). Essentially, the person enters an introspective state of mind that allows them to internalise the events from their past. In doing so they are able to grasp the various life outcomes resulting from these tragic events. Unlike other hallucinogenic drugs, ibogaine does not cause any distortions in reality or thought disturbances (erowid). What the person experiences during the treatment are thoughts and feelings that come from within, without any outside influence. This allows for an uninterrupted reality based therapy without any distortions. The person gains perspective on their past, present, and future. This perception is not influenced by environmental factors that cause distortions. A recent study involving veterans struggling with PTSD has helped elaborate on this framework.

The therapeutic benefits of ibogaine had been speculated to aid veterans who had witnessed ongoing trauma during wartime. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359647/)

The introspective experience of the ibogaine would be crucial to these trauma victims, since they have experienced so many events that they do not even know which ones have caused them the most pain. Through the introspective experience of ibogaine, the person is able to relieve their past, knowing which events have caused them the most pain and find an internalised solution to this problem. These experiments showed exceptional success as more than 80 percent of the participants reported. Significant decreases in levels of depression and anxiety for months after the treatment.

In conclusion, ibogaine hydrochloride shows promises of success on both a biological and psychological level. This is essential in the treatment of post traumatic stress disorder, since both the mind and brain suffer disturbances as a result of trauma. Ibogaine helps rewire the chemical makeup of the brain to a pre traumatic state. While this is occurring, the mind is influenced to the point where a person received an internalised form of therapy via introspection. Everyone deals with trauma in their own way. The ibogaine treatment provides a solution geared towards an individual person's particular needs.


 
Last edited:



How psychedelics helped me feel safe in my body, in my pleasure, in my vulnerability, and in love*

by Mareesa Stertz | LUCID News | 20 Jan 2021

I now know what it’s like to have found the frequency of safety, and to feel safe in my body, in my pleasure, in my vulnerability, and in love.”

In this episode of Adventures of the Psyche we are joined by Dena Justice, who shares how a series of psychedelic journeys unraveled deep patterns of co-dependency, control, disassociation, and physical unwellness stemming from childhood sexual abuse.

Dena spent most of her life highly anxious, sleep deprived, disassociated from her body, and haunted by memories of childhood abuse – and thought there was nothing wrong. It took five years of psychedelic work, and other healing modalities, to help her unpack her childhood trauma, and feel truly alive.

Dena is the founder of Psychedelic Ministry and Ecstatic Collective. As a master coach and certified trainer, she certifies others in Neuro-Linguistic Programming (NLP), Time Line Therapy®, Hypnotherapy, and NLP Coaching. She integrates these practices into non-ordinary states of consciousness (such as meditation, breathwork, movement, and psychedelics).

Join filmmaker and host Mareesa Stertz for a brief visit into other realms where guests share personal stories of illumination, healing, and transformation through their use of psychedelics.

*From the article here :
 
psychedelics1-821.jpg



Why some therapists are risking arrest to heal trauma using psychedelics

by Aaron Ernst | Al Jazeera

For years, Andreas struggled to let go of the childhood physical and emotional abuse he suffered at the hands of his father. For him, the verbal abuse was the worst.

“I would have taken a beating any day than to be told that, ‘You’re a piece of s—t,’” said Andreas, who asked we not use his last name. “A punch heals; words don’t. Words stick with you for a long time.”

Years of conventional talk therapy did little to help. And as time passed, the traumatic memories became more and more intrusive.

“I found myself in self-destructive patterns – drug abuse, just not taking care of myself,” he said. “I had violent outbursts that would happen a lot, too.”

Then, one of the therapists he was seeing made a surprising suggestion: Andreas would perhaps get more out of therapy if he was under the influence of drugs, specifically psychedelics. He gave Andreas a number to call.

“I set up an interview, sat down, talked, and decided that this is something I wanted to pursue,” he said.

Andreas had stumbled into an underground world of therapists and self-described healers who are treating traumatic memories with the help of drugs, like MDMA, LSD and psilocybin. After just a few sessions of treatment with MDMA, Andreas says the anger and resentment he’d felt towards his father for decades just melted away.

“You realize that you're not that scared kid anymore. All those defense mechanisms that you built up when you were a child, you don't need that anymore,” he said.

“You're not under threat from your father anymore. You haven't even seen your father in 40 years, what are you scared about?”

Andreas says the therapy changed his life, and that he is no longer trapped in the past.

“No matter what can get thrown at you, you realize that it's really not that big of a deal,” he said. “As long as you're breathing, it's OK.”
Building a connection

While Andreas’ sessions have been life-altering, what he is doing could land him in jail. Decades ago, the government placed psychedelics in the same category as heroin and meth — drugs with a high potential for abuse and no legitimate medical purpose.

New research, however, is beginning to call the government’s hard line into question.

“It’s education that is important,” said Neal Goldsmith, a psychotherapist who helps to organize the annual “Horizons” conference, a gathering of scientists who are doing research into the therapeutic benefits of psychedelics.

One prominent attendee at the most recent “Horizons” conference was Rick Doblin, founder of MAPS, an organization that has poured tens of millions of dollars into psychedelic research.

“Psychedelics are a way to build a connection with others, to build empathy, to build spiritual experiences,” Doblin said.

A flurry of recent clinical trials done by MAPS and other institutions, such as NYU and Johns Hopkins University, have shown psychedelics to be effective in treating a broad range of neurological disorders, from depression and addiction to anxiety and even autism.

And unlike antidepressants, patients given psychedelic-assisted therapy don’t need to be medicated for an extended period of time.

“It’s not meant to be like a daily medication that changes people’s biochemistry,” Doblin said. “People only get MDMA three times in our treatment process. People only get psilocybin or LSD a few times. The goal is to actually cure the problem.”

One of the most promising applications is one familiar to trauma survivors like Andreas: the use of psychedelics and therapy to take the sting out of traumatic memories.

“The results have been extremely promising in terms of outcomes,” Doblin said. “In fact, so promising that some of the people that have looked at the data said that it’s too good to be true.”

In one study funded by MAPS, war veterans with treatment-resistant PTSD were given MDMA along with psychotherapy. After just a few sessions, 83 percent of participants no longer fit the criteria for PTSD.

In the case of PTSD, Doblin says that psychedelics appear to work by allowing a patient to recall the painful past, while excising the visceral fight-or-flight reaction that normally accompanies traumatic memories.

“They reconsolidate, or restore the memory, in a different way so that it's not connected to the fear,” he said.
‘The beast is there’

Doblin is hopeful that the FDA-approved clinical trials currently underway will lead to the legalization of psychedelic-assisted therapy in the coming decade. He understands why some therapists have chosen to incorporate psychedelics into their practice though the drugs remain illegal.

“I’m not going to recommend the practice, but I’m not going to condemn it either,” he said. “I think it’s a point of conscience that everybody has to say, ‘I think the laws are immoral. The laws are wrong. We should have been able to do this research 30 years ago.’”

It took several weeks of searching and multiple conversations with an intermediary, but a self-described healer who uses psychedelics to treat trauma in his clients finally agreed to speak with America Tonight about his practice. The healer, who we’ll call Simon to protect his identity, says he uses the drugs to help those suffering traumatic memories caused by everything from combat to childhood abuse.

“A vet that I’ve worked with has had four sessions. And now, I never hear from him … ’cause he’s going to Mets games with his son,” he said. “I’ve seen examples like that over and over. I don’t use the word ‘miracle’ because it’s so loaded, but it is close.”

Simon says he uses the same protocols as those in the FDA-approved clinical trial for treating PTSD with MDMA. While he is not a licensed therapist, Simon uses his training as a spiritual psychologist to help clients revisit their trauma, and with the help of the drug, move past it.

“It’s like looking at a shark in a tank at an aquarium,” Simon said. “The beast is there. It’s only feet away, but it’s not going to touch you.”

Word of his success has spread quickly by word of mouth. He says he’s seen hundreds of trauma sufferers and that the intake of new clients is relentless. He remains acutely aware that what he’s doing is illegal, but as someone who struggled with trauma in his youth, he says it’s worth the risk.

“I am breaking the law, I totally understand that,” he said. “But it seems to me that with the greatest respect, there are some laws that are so foolish, so misguided and so based on out-of-date information. That’s the tragedy.”

It will be years before the government decides whether to legalize psychedelic-assisted therapy. Until then, this underground movement of therapists, and their clients who have experienced the healing power of psychedelics first-hand, will continue to quietly use the drugs.

For Andreas, he hopes his decision to speak on camera about his experience will help to make the use of psychedelics by others wrestling with the same feelings, more acceptable.

“This needs to be out there,” Andreas said. “All this trauma and all this PTSD and all these problems are going to keep getting passed down. The ripple effects are quite huge.”

 
Last edited:
4672.jpg

Soldiers, who have been traumatised by active service, are using psilocybin
to treat their flashbacks and anxiety.


Magic mushrooms could help ex-soldiers overcome trauma

by Jamie Doward | The Guardian

As more troops self-medicate with psychedelic drugs to help with PTSD, a group of experts lobby for proper clinical trials.

A growing number of soldiers suffering from post-traumatic stress disorder are turning to “magic mushrooms” and LSD to treat their condition. But drug laws make it almost impossible to establish whether they work.

Now a new body, the Medical Psychedelics Working Group, a consortium of experts, academics, researchers, policy specialists and industry partners, is to begin lobbying for a change in the law so that scientists can conduct clinical trials.

“This is something that’s been developed by veterans,” said Professor David Nutt from Drug Science, an independent scientific body which calls for an evidence-based approach to the legislation and is part of the group.

“Three years ago if I was asked the question would psilocybin work for veterans, I would have said it would be quite dangerous to relive the trauma when tripping. But so many vets are doing it now that I’m convinced it can work.”

It is estimated that 17% of people who have seen active military service report symptoms such as flashbacks, nightmares, anxiety, depression, grief and anger.

Earlier this year a team at the Medical University of South Carolina reported on clinical trials which found that PTSD sufferers who used magic mushrooms as part of their therapy showed greater levels of improvement compared with patients who did not receive the drug.

But such clinical trials are difficult in the UK because LSD and magic mushrooms, which were legal until 2005, are classed as Schedule 1 drugs.

The classification means it costs around £3,500 for a licence from the Home Office to conduct tests using the drugs, and the application process can take a year. Scientists face prison sentences if the drugs fall into the wrong hands.

720.jpg


“But when ex-servicemen and women in the UK are reporting how their own use of psychedelics is having a marked effect on PTSD symptoms, we need to restart our studies,” Nutt said. “It could be that these substances can improve the lives of countless people who are suffering with debilitating and life-diminishing mental health conditions.”

Guy Murray, an infantryman with the 4th Battalion The Rifles, served on a long tour of Helmand Province, Afghanistan where his best friend and many other colleagues were killed by the Taliban. He was diagnosed with PTSD in 2017, after suffering from suicidal thoughts, anxiety and severe depression for several years.

After watching a Ted Talk about psilocybin and depression, he began experimenting with magic mushrooms, and then, under specialist supervision, was given LSD.

“It allowed me to address things which I was not open to addressing and it has honestly changed my life,” Murray said. “I believe I left my PTSD behind in those sessions. I am no longer destructive or closed off. I have my life back.”

Crispin Blunt, Conservative MP for Reigate, who served with the 13th/18th Royal Hussars, said that Murray’s experiences were common among the armed forces.

“About a third of veterans with PTSD from recent conflicts, estimated by some to be 2,400 individuals, have the condition so seriously as to be beyond recovery from current treatment practice,” Blunt said.

“We need to provide a safe, professional and lawful route of access to novel treatments such as psilocybin, collecting evidence and calling for our drug laws to be evidence based so our servicemen and women are not forced to travel to other countries, go underground or break the law to obtain treatment that works.”

 
Last edited:
MDMA-18-927x617.png



MDMA proven to help those with trauma

by David Nutt | The Independent

When MDMA (later known as ecstasy) was discovered by Shulgin in the 1950s, he noted that it had very special properties of calmness, clarity and empathy that set it apart from the many other chemically related amphetamine-like drugs. He then told this to his wife, who was a psychotherapist and who agreed and suggested that these properties were ideal as a medicinal adjunct to psychotherapy.

She shared this knowledge and the drug to many therapists in the west coast of the US. They concurred with her analysis: MDMA was a real breakthrough in treatment, the first drug that could augment psychotherapy in which it was called “empathy.” It was especially useful in couples counselling where the empathy-enhancing effects could break down the years of tension and irritations with the partner that often build up in marriages and slowly crust over the early love and desires.

All was well until the MDMA was recruited by the rave scene as a “dance drug” and renamed ecstasy. This led to a backlash from the media who hated the idea of young people becoming ecstatic, and developed a campaign of moral panic to get it banned. Horror stories of brain damage were invented and the few deaths massively publicised in relation to the harms of MDMA compared with other drugs such as alcohol. This campaign worked and ecstasy was banned across the globe at the end of the 1980s, despite eloquent and compelling protestations from the many therapists that had used it and patients who had benefited.

MDMA is still illegal today despite the supposed scientific evidence of harm being largely discredited. Schedule 1 drug research with MDMA is hugely difficult and expansive but there is growing evidence of therapeutic value and neuroscience studies, such as the new Gabay et al. paper, revealing that there is a strong scientific rationale behind its use.

A coalition of therapists in the US under the banner of MAPS has fought for more than 30 years to keep the therapeutic potential of MDMA alive. They have raised charitable funds to allow MDMA to be evaluated in its use treating people with resistant post-traumatic stress disorder. Several studies have been commissioned that cover both war and other causes of trauma. They show that just two psychotherapy sessions with MDMA as part of a psychological treatment course can massively improve PTSD – often resulting in a full recovery in patients who had to that point been resistant to other conventional forms of treatment such as the SSRI antidepressant medicines and cognitive behaviour therapy.

In light of these successes we have begun to treat people who have become alcohol dependent with MDMA in an attempt to deaden the mental pain of prior traumas. Such individuals are very common, indeed the norm, in alcohol treatment services and have a massively high failure rate with conventional abstinence-based treatments. Less than a quarter stay dry for three months, while those who carry on drinking for the rest of their lives have their life expectancy cut by 20 years. So far we have treated five people with the standard Maps protocol of two MDMA sessions two weeks apart, as part of the standard post-detox follow-up sessions. Up to this point all have stayed abstinent for the duration of the trial, which is still recruiting and will finally report next summer.

So how does a dance drug have such a powerful therapeutic effect? The answer, we believe, is because of its unique pharmacology that leads to its special psychological effects. MDMA releases serotonin, the neurotransmitter that we now know is involved in social bonding as well as in reducing anxiety and lifting depression. MDMA also releases dopamine, which is why it can be used to give energy for all night raves, but this is a secondary and lesser action. In the quiet of the therapeutic treatment room the dopamine release may help keep patients motivated and engaged with the therapist, but it’s the ability of the serotonin to overcome fear and anxiety that’s critical.

The current best treatment for PTSD involves reliving the trauma and gaining mastery over the emotions that emerge. For many severely traumatised individuals this is not easy: the memory can invoke such severe anxiety that the person can’t cope and leaves the room or they dissociate so can’t engage with the therapist. Our own brain-imaging study showed that MDMA dampens down the anxiety circuit of the brain and so reduces the impact of reliving negative memories.

This new study shows it enhances trust, which is vital in the therapeutic situation where the therapist is asking the patient to re-engage with memories they would rather forget. Together these neuroscientific advances give a firm rationale for the use of MDMA in PTSD therapy and support the call that I and many others have been making that it should be taken out of the controlled drugs list and put back into the medicine cabinet.

https://www.independent.co.uk/voice...d-trauma-trust-david-nutt-gabay-a8643031.html
 
landscape_nature-118368.jpg%21d



Understanding anger in addiction recovery

by Seth Blais | The Times Record | 24 Feb 2020

I locked my anger up in solitary confinement with my other emotions during a decade of drug use. Letting it back into the world has proven challenging.

For a long time, I used drugs to snuff out my emotions. I’d utilize any tool I could find to achieve this, but heroin seemed to work the best for me. I would do anything to avoid feeling pain and being honest with myself. Avoidance is a response that I learned through experiences in my childhood, and it has affected me negatively in my adult life. You can read more about this in my previous article.

I no longer use heroin to deal with painful emotions. This dramatic change has left me scrambling to learn new ways to manage these feelings and my response to them. One response to the emotional pain that I’ve struggled with, is anger.

My anger has exploded on co-workers, loved ones, strangers. Sometimes the anger was justified, but it was never helpful. I’ve spent hours inside my own head thinking about how someone has wronged me or caused my anger, only to make the feelings intensify.

Beneath all of our anger lies hurt. Have you ever stubbed your toe on a piece of furniture and then instantly became angry? You placed the furniture where it stands and you’re in control of your feet, so who are you angry with? It’s a response to the pain you felt. It works the same way with emotional pain.

Almost everyone who suffers from addiction has trauma in their past and struggles with how to process the pain from those events. Not everyone with trauma struggles with addiction, but many people, including myself, do. Struggling to navigate feelings of anger are common in addiction recovery.

Anger doesn’t just disappear when we suppress it. Anger suppression has always caused me to build up like a pressure cooker until I explode. Instead, I’m trying to understand it differently as a secondary emotional reaction, so I can make better decisions in emotional situations.

I locked my anger up in solitary confinement with my other emotions during a decade of drug use. Letting it back into the world has proven challenging.

images


Understanding anger as a secondary emotion

What is the emotion that’s being overshadowed by my anger?

This is one question that has recently helped me take a step back and think about why I feel the way that I do. Typically, another emotion, like fear or sadness, can be found underneath the anger. Fear includes things like anxiety and worry, while sadness comes from the experience of loss or disappointment.

You may fear something or someone, but more often the greater fear is that of having your ego damaged or of being abandoned. Understanding the root causes of anger is the first step to addressing them in a better way.

I recently experienced something personally that would have normally sent me into a rage. My first impulse was to become angry, which is normal and maybe even justifiable in this situation. The problem is that when I allow anger to take the wheel, it can be almost impossible to regain control. I will burn the entire house down while I’m still standing inside of it. The consequences of my anger are almost always worse than the reason causing it.

Instead of completely letting anger take control, I asked myself the question above. What emotion is being overshadowed by my anger? I realized that I was covering up sadness and my ego was damaged. I wanted to blame another person for causing me to feel the way that I did.

In the year 1858, Abraham Lincoln and Stephen Douglas engaged in seven political debates aptly referred to in our history books as the Lincoln-Douglas debates. Douglas was up for re-election in the United States Senate and Lincoln hoped to defeat him. These debates happened a few years before Lincoln would become President, and slavery was a very hot political topic.

During their first debate, Lincoln passionately expressed his hate for slavery and even expressed his hatred for the attitude of being indifferent towards such injustice. He then paused and made a statement regarding Southern people who supported slavery at the time.

“They are just what we would be in their situation,” he said.

Lincoln realized that sometimes the actions of people are merely the result of their own circumstances. I’m not trying to compare the Lincoln-Douglas debates of 1858 and my personal daily struggles, but this one sentence has stuck with me. It’s helped me to look beyond anger, being strict with my own emotional responses while being forgiving of other people.

The hard truth is that your circumstances don’t care how you feel about them, and sometimes people in your life don’t either. As that old and seemingly not attributable saying goes: Holding onto anger is like taking poison and expecting the other person to die. Every situation is made better with a calm mind. Without the ability to control your anger, you become a prisoner to it.

 
file-20170515-7011-1n02579.jpg



Why understanding Inherited Trauma is critical, and what it means for our kids

by Kelly Hoover Greenway | Washington Post | 19 Jul 2021

In the weeks leading up to the birth of his second child, Britain’s Prince Harry spoke about his mental health struggles, which in part led him to step down as a working member of the British royal family. He discussed on the “Armchair Expert” podcast wanting to “break the cycle” of trauma in his family, suggesting that even when parents are mindful of their past trauma, “there’s a lot of genetic pain and suffering that gets passed on anyway.”

That idea, what researchers call “inherited trauma,” is far more complicated a concept than his declaration would have us believe. The research is relatively new, but many experts think what it suggests is that inherited trauma is our biology looking out for us, even if it may not appear that way at first.

While not many of us can relate to Prince Harry’s royal life or the trauma he endured after his mother’s death when he was 12 years old, it’s estimated that more than two-thirds of children experience at least one traumatic event by age 16. Abuse, violence, national disasters, severe illness and neglect are examples of trauma that researchers think could play a role in how future generations respond to their surroundings.
Advertisement

Bianca Jones Marlin is an assistant professor of psychology and neuroscience and principal investigator of the Marlin Lab at Columbia University’s Zuckerman Institute. She said that inherited trauma is not about traumatic life events being able to change our DNA (or that of our children), but rather “a memory of a traumatic event in our ancestors living on in us.” Exactly how it lives on, and for what reason, is what researchers aim to discover.

The seminal study on the matter centers on the “Dutch Hunger Winter” of 1944-45 during World War II, when Nazis occupying the Netherlands restricted food transport as punishment for the Dutch government’s support of the Allies. A harsh winter and bad crops left the population with rations of less than 900 calories per day for months. Twenty-two-thousand people died.

Decades later, scientists began researching the offspring of women who were pregnant during this time. What they found, in part, was that they were heavier than average, had higher levels of triglycerides and LDL cholesterol, and were more prone to obesity and diabetes. Even though there was no longer a risk of starvation for these offspring, it appeared that the “memory” Marlin mentioned was trying to protect their bodies from a land with no food.

The pandemic is traumatic for kids like mine. I have no idea how to help them.

Scientists have also looked at the existence of inherited trauma in groups such as the children of Holocaust survivors, Native American communities and the sons of Civil War prisoners of war, to name a few. And though the findings seem to support the idea that trauma did, in fact, lead to changes in future generations, critics have noted small sample sizes, exaggeration of causality and media sensationalism as reasons to doubt them.
Advertisement

Marlin, who conducts her research on mice, supports making sure the “science is rigorous” and acknowledges issues with data from others in the past. However, she said that “if I take a step back from being a scientist and am just a fellow human in society, we see inherited trauma playing out in many instances across the world; it makes sense. Now we need to identify the biology behind this inheritance, which will help us better understand and navigate the stresses of our world today.”

Experts said that studying inherited trauma is not meant to disempower or blame parents for things they cannot control. “When we think about inheriting trauma, we think of something that is not good, but really what we’re saying is that our bodies are resilient and trying to offset any potential traumas by allowing us to survive, and ultimately to thrive,” says Courtney Bolton, a Nashville-based child and family psychologist. “The issue becomes when those modifications to our genes no longer serve us.”

From a clinical perspective, Bolton thinks the research can lead to more targeted interventions and treatments for clients. “Let’s say, hypothetically speaking, inherited trauma created a gene mutation that made children more sensitive to noise as a defense mechanism. If you were prepared for that early on, then you could proactively provide intervention to help with anticipating noises, regulating anxiety and, ultimately, being able to tolerate loud noises. The more we understand how genetics influence our interaction with the environment, the better we can create behavioral interventions to offset that.”
Advertisement

For parents and caregivers who believe past trauma may be playing a role in their children’s lives, Bolton emphasizes establishing a safe and secure environment, with soft, physical touch playing a critical role. “As adults, we can mentally soothe ourselves by rationalizing or planning, but for young children, hugs, rubbing backs and snuggling can help them regulate their emotions. If we can use safe, loving touch to help children bond, regulate emotions and ultimately overcome inherited anxieties, then we can shift developmental trajectories in really positive ways.”

Bolton also notes that when it comes to seeking therapy for your child, it’s important for parents to be forthcoming about their history — whether they recognize certain events as “traumatic” or not.

I learned the impact of prolonged exposure to stress from my foster child

Currently, scant researchers are dedicated to this field of study — “a few brave souls,” as Marlin refers to them. One is Moriah E. Thomason, associate professor of child and adolescent psychiatry at New York University’s Grossman School of Medicine. Thomason’s drive comes from wanting to find earlier interventions for children who are suffering. “The fact that children are struggling from developmental disorders and challenges achieving landmarks that humans need to achieve is devastating,” she says. “As a scientist, I’m looking at a child’s symptoms, but I’m trying to get to the core. What is the purest representation of a developmental disorder?”

Her most recent work, a study she co-authored in 2020 exploring the potential impact of maternal childhood trauma on child behavioral problems, looks at certain brain activity as a possible indicator of how inherited trauma biologically presents in children.

Beyond helping to understand and treat individual cases of mental health more effectively, better understanding inherited trauma could also lead to more significant changes in society regarding groups of people who have experienced trauma because of systemic oppression, such as those affected by colonization (in this case, the descendants of the Indian Residential Schools system in Canada), slavery and racism. Thomason is most passionate about this aspect of the work. “To get economic and government support to help break these cycles of trauma, you’ve got to know that there’s a cycle, and you have to show it to people,” she says. “There’s a socio-demographic story here, and there are individuals at greater risk. We have to do this work for them. It’s critical.”

Kelly Hoover Greenway is an Austin-based television producer and writer whose work focuses on parenting and relationships, women’s health, and personal essays.

 
M0016133619--602022.JPG

Dr. Daniel Sumrok

Is Childhood Trauma the Root Cause of Addiction?*

by Jane Ellen

"When you’re a child, you can’t control the people who abuse and assault you, who create hostile environments. If a child can’t control their environment, because of these things they grow up thinking they’re bad, different, horrible people. This new approach helps them feel like they’re not drowning anymore."

Introducing Dr. Daniel Sumrok, director of the Center for Addiction Sciences at University of Tennessee’s College of Medicine. The center is the first to receive the Center of Excellence designation from the Addiction Medicine Foundation, a national organization that accredits physician training in addiction medicine. Sumrok is also one of the first 106 physicians in the U.S. to become board-certified in addiction medicine by the American Board of Medical Specialties.

"Addiction shouldn’t be called “addiction,”it should be called “ritualized compulsive comfort-seeking,” says Dr. Sumrok. "Ritualized compulsive comfort-seeking is a normal response to the adversity experienced in childhood, just like bleeding is a normal response to being stabbed."

"The solution to changing ritualized compulsive comfort-seeking behavior to address a person’s adverse childhood experiences (ACE) individually and in group therapy; treat people with respect; provide medication assistance in the form of buprenorphine, an opioid used to treat opioid addiction; and help them find a ritualized compulsive comfort-seeking behavior that won’t kill them or put them in jail. My patients seem to respond really well to this,” he says.


Sumrok, a family physician and former U.S. Army Green Beret who’s served the rural area around McKenzie, TN, for the last 28 years, combines the latest science of addiction and applies it to his patients, most of whom are addicted to opioids. He sees them in the center’s two outpatient clinics: his clinic, which the Center for Addiction Science ha taken over as its rural clinic, and another that opened recently in downtown Memphis.

Since he first sat down in the early 1980s to write a research paper (“Public Health Legacy of the Vietnam War: Post-Traumatic Stress Disorder and Implications for Appalachians”) to describe the symptoms of the newly named post-traumatic stress disorder in Vietnam veterans – “problems with the law, having trouble sleeping, anxiety, divorce, sleep troubles, substance use disorders, depression, anxiety, cognitive and chronic pain issues” — Sumrok has pieced together the ingredients for a revolutionary approach to addiction. It’s an approach that’s advocated by many of the leading thinkers in addiction and trauma, including Drs. Gabor Maté, Lance Dodes and Bessel van der Kolk. Surprisingly, it’s a fairly simple formula: Treat people with respect instead of blaming or shaming them. Listen intently to what they have to say. Integrate the healing traditions of the culture in which they live. Use prescription drugs, if necessary. And integrate adverse childhood experiences science: ACE.

ACE understanding changes practice

Learning about ACE more than two years ago was a big turning point for his understanding of addictions, explains Sumrok. “I was working in an eating disorders clinic and someone told me ‘90 percent of these folks have sexual trauma’. I remember thinking: That can’t be right. But that was exactly right. Since I’ve learned about ACE, I talk about it every day.”

He also practices it every day, by integrating ACE assessments for all patients in his clinics. He currently has about 200 patients who are addicted, most to opioids (heroin and prescription pain relievers, including oxycodone, hydrocodone, codeine, morphine, and fentanyl). “I’ve seen about 1,200 patients who are addicted,” he says. “Of those, more than 1,100 have an ACE score of 3 or more.”

Sumrok knows that score says a lot about their health and ability to cope: ACE comes from the CDC-Kaiser Permanente Adverse Childhood Experiences Study (ACE Study), groundbreaking research that looked at how 10 types of childhood trauma affect long-term health. They include: physical, emotional and sexual abuse; physical and emotional neglect; living with a family member who’s addicted to alcohol or other substances, or who’s depressed or has other mental illnesses; experiencing parental divorce or separation; having a family member who’s incarcerated, and witnessing a mother being abused. Subsequent ACE surveys include racism, witnessing violence outside the home, bullying, losing a parent to deportation, living in an unsafe neighborhood, and involvement with the foster care system. Other types of childhood adversity can also include being homeless, living in a war zone, being an immigrant, moving many times, witnessing a sibling being abused, witnessing a father or other caregiver or extended family member being abused, involvement with the criminal justice system, attending a school that enforces a zero-tolerance discipline policy, etc.

The ACE Study is one of five parts of ACE science, which also includes how toxic stress from ACE damage children’s developing brains; how toxic stress from ACE affects health; and how it can affect our genes and be passed from one generation to another (epigenetics); and resilience research, which shows the brain is plastic and the body wants to heal. Resilience research focuses on what happens when individuals, organizations and systems integrate trauma-informed and resilience-building practices, for example in education and in the family court system.

The ACE Study found that the higher someone’s ACE score – the more types of childhood adversity a person experienced – the higher their risk of chronic disease, mental illness, violence, being a victim of violence and a bunch of other consequences. The study found that most people (64 ercent have at least one ACE; 12% of the population has an ACE score of 4. Having an ACE score of 4 nearly doubles the risk of heart disease and cancer. It increases the likelihood of becoming an alcoholic by 700 percent and the risk of attempted suicide by 1200 percent. (For more information, go to ACE Science 101. To calculate your ACE and resilience scores, go to: Got Your ACE Score?)

High ACE scores also relate to addiction: Compared with people who have zero ACE, people with ACE scores are two to four times more likely to use alcohol or other drugs and to start using drugs at an earlier age. People with an ACE score of 5 or higher are seven to 10 times more likely to use illegal drugs, to report addiction and to inject illegal drugs.

The ACE Study also found that it didn’t matter what the types of ACE were. An ACE score of 4 that includes divorce, physical abuse, an incarcerated family member and a depressed family member has the same statistical health consequences as an ACE score of 4 that includes living with an alcoholic, verbal abuse, emotional neglect and physical neglect.

Subsequent research on the link between childhood adversity and addiction corroborates the findings from the ACE Study, including studies that have found that people who’ve experienced childhood trauma have more chronic pain and use more prescription drugs; people who experienced five or more traumatic events are three times more likely to misuse prescription pain medications.

Sumrok%2520group.jpeg

Dr. Dan Sumrok with group therapy members at McKenzie, TN, clinic.

“ACE doesn’t just predict substance abuse disorders,”
says Sumrok. “Major chronic diseases are so often linked to substance abuse, this is too big to ignore.”

Whether you’re talking about obesity, addiction to cigarettes, alcohol or opioids, the cause is the same, he says: “It’s the trauma of childhood that causes neurobiological changes.” And the symptoms he saw 40 years ago in soldiers returning from Vietnam are the same in the people he sees today who are addicted to opioids or other substances or behaviors that help them cope with the anxiety, depression, hopelessness, fear, anger, and/or frustration that continues to be generated from the trauma they experienced as children.

Learning about ACE helped him understand that the original definition of PTSD, which many people still cling to, is not accurate. In the 1980s, PTSD was defined as a result of trauma that was outside the realm of normal experience.

“That was just wrong,” says Sumrok. “Divorce, living with depressed or addicted family members are very common events for kids. My efforts are around helping people to see the connections, and that their experiences are predictable and normal. And the longer the experiences last, the bigger the effect.”

He also says, “Drop the ‘D’, because PTSD is not a disorder.” It’s what he learned from van der Kolk, who wrote The Body Keeps the Score. “Bessel says we’ve named this thing wrong. Post-traumatic stress is a brain adaptation. It’s not an imagined fear. If one of your feet was bitten off by a lion, you’re going to be on guard for lions,” explains Sumrok. “Hypervigilance is not an imagined fear, if you’ve had one foot bitten off by a lion. It’s a real fear, and you’re going to be on the lookout for that lion. I tell my patients that they’ve had real trauma that’s not imagined. They’re not crazy.”

Patients who learn about their ACE understand that they can heal

This is what happens when a person sees Sumrok for the first time: They fill out the 10-question ACE survey (Got Your ACE Score?) in the waiting room. “Then when I see them, I go through each question and ask them again,” says Sumrok, who also does a normal physical exam. “Frequently, there’s a difference between the two. For example, this morning, I saw a woman and she reported an ACE score of 1 on the survey. Then, when I asked her the questions, she reported nine out of 10.”

That’s just how I grew up, she told Sumrok. She didn’t think being beaten, humiliated or seeing her mother smoking crack every day was harmful or unusual, especially since most kids she knew were experiencing the same thing.

Sumrok normalizes their addiction, which he explains is the coping behavior they adopted because they weren’t provided with a healthy alternative when they were young. He explains the science of adverse childhood experiences to them, and how their addictions are a normal – and a predictable – result of their childhood trauma. He explains "what happens in the brain when they experience toxic stress, how their amygdala is their emotional fuse box. How the thinking part of their brain didn’t develop the way it should have. How it goes offline at the first sign of danger, even if they’re not connecting the trigger with the experience. Drugs like Zoloft don’t really help much," he tells them. "Zoloft and other anti-depressants don’t remove the memory triggered by the odor of after shave that was worn by your uncle who sexually abused you when you were eight, or the memory triggered by a voice that sounds just like your mother who used to beat you with a belt, or by a face of a man who looks like your father who used to scream at you about how worthless you were…" The examples are infinite. That’s why van der Kolk says, “’The body keeps the score’,” Sumrok says.

“After I explain all this to them, many of them stare at me and say: ‘You mean I’m not crazy?’” says Sumrok. “I tell them, ‘No, you’re not crazy’.” Sometimes he yells out the door to his nurse: "Patsy! Where’s my not-crazy stamp? I need to stamp this person’s chart.”

For people who are addicted to opioids, he prescribes buprenorphine (one of the brand names: Suboxone), which helps them to withdraw from opioids and to keep their job, or return to work. For most people, the drug is less addictive than other opioids. Sometimes if people are young, healthy and haven’t been addicted long, they can withdraw from opioids without buprenorphine.

“There’s no buzz associated with buprenorphine,” says Sumrok. “They can concentrate and think. Once they’re free of the continuous distraction of the acquisition and use of substances, they become pretty valuable employees.”

For people who are addicted to alcohol, he prescribes naltrexone (one of the brand names: Revia), because alcoholics have a high risk of death if they aren’t provided medication. And in this current national attention on opioids, Sumrok is careful to point out that although 33,000 people died from opioid overdose in 2015, 88,000 people die annually from alcohol-related causes, and 480,000 from cigarette smoking. The complicating factor — and why policies don’t work when they chase the eradication of one drug, only to focus on eradicating the next popular drug of choice for “ritualized compulsive comfort-seeking” — is that many people use opioids and alcohol and cigarettes. And if they receive no help to get at why they’re using legal or illegal substances, they will move on to another, more easily accessible drug when the current drug they’re using becomes more difficult to find.

All patients sign a contract agreeing that they won’t drink alcohol or take other drugs. “We don’t mess around with that,” says Sumrok. “We can’t deal with them being deceptive, because if they drink or do other drugs, it can kill them. If their drug screens aren’t consistent, we ask them to find another doctor. Just about everybody stays," he says.

They also participate in group therapy. For physicians who prescribe buprenorphine, it’s now required, but Sumrok had seen the research about the effectiveness of group therapy, and had started 12-step groups for his patients about 10 years ago. Talking with others who have the same experiences helps each person normalize their own experiences. Sumrok and the others in the group help each other find “ritualized compulsive comfort-seeking behaviors” that won’t kill them or put them in jail, such as coaching their kid’s soccer team or volunteering at a food bank. Sumrok encourages them to integrate other rituals into their lives, such as walking 30 minutes a day or other exercise, joining a 12-step group or finding a path to encourage a spiritual awakening.

“Six months into this,” says Sumrok, “they start saying things like, ‘My wife and I are back together,’ or they’re hanging out with their kids. It’s pretty cool to see how people get their lives back. My favorite word is ‘normal’. When they tell me they feel normal, I know they’re doing okay.”

So, how long does it take before they’re cured? “How long should you take insulin if you have diabetes?” responds Sumrok, making the point that this is a chronic disease, that people should be in treatment for as long as it is necessary, and that some may relapse. His goal is for them to not have to use buprenorphine, but he knows that because of the number and duration of their ACE, and the paucity of resilience factors provided to them when they were children, many will need continual support. He helps them learn how to integrate that support into their lives.

“When a diabetes patient comes in with a blood sugar level of 300, we don’t say: ‘Give me back that insulin.’ We intensify the treatment to get them back in balance,” explains Sumrok. “Only in addictions do we shame people. We tell them they can’t be part of this recovery anymore. We create a teeny hoop that’s called abstinence, and not too many people can jump through that hoop. If every time we saw a diabetic, we told them that their kidneys were going to fail, they would be blind and we would amputate their extremities, there wouldn’t be many diabetics who got help. I have patients who drop out, and then return a couple of months later, and say, ‘Doc, Christmas came, I saw some of my buddies, and I started using again.’ I tell them, ‘Come on in. Let’s work with you.’ And I remind myself that I’m not saving souls, I’m saving their asses. It’s about getting them so they can function at work, at home, at play. It’s not about making them perfect human beings."

“It has been abundantly clear to me and reinforced over a 40-year career,”
continues Sumrok, “that patients desire, and respond better to, sensitive and informed care. From the Navajo Nation, to Appalachia, to Memphis, to the mountains of Honduras, to the jungles of Amazonia - people regard respect as the sine qua non of quality care.”

Stories AND data drive solutions

Although Sumrok thinks his approach benefits his patients, he knows he needs data to prove it. When he saw a recent study that said 43% of people on buprenorphine were using other opioids, he did his own analysis of a sample of his patients, and found that only 8% were using other opioids. After tracking down those who were, most had good reasons, such as a man whose arm and shoulder were in a new cast after surgery repairing an injury, and he was taking a narcotic. Only one did not, and when shown his drug test, he said, "'You know what? I slipped.' He talked about it in group," says Sumrok, and everyone in his group hovered around him to make sure he’d continue the program.

Derefinko.jpeg

Dr. Karen Derefinko

Because Sumrok has kept fastidious records of the patients who have done their ACE scores, Dr. Karen Derefinko, a clinical psychologist and assistant professor in the Department of Preventive Medicine at the University of Tennessee Health Science Center, is starting a research project to examine all 1,200 records in Sumrok’s clinic in McKenzie to look at the relationship between people’s ACE scores and their adherence to treatment and their relapses.

“We think that people with high ACE scores are likely to have more relapses,” she says. “And that may be because people with higher scores have fewer resources and more difficulty associated with adhering to their treatment plans.”

She and her research assistant will de-identify the records, so that all information is anonymous, and then collect the data. Once that data is analyzed — probably within two months — Derefinko and her assistant will conduct focus groups of some of Sumrok’s patients. She’s already been sitting in some of the groups.

“Dan encourages this participatory nature of his groups,” she says. “People are very willing to talk. After the group sessions, they’re often not done talking about why they came to Sumrok and why other programs didn’t work for them.”

Through the records and the focus groups, Derefinko hopes to identify barriers to care, which include basics such as how people can find good care easily (most of Sumrok’s patients find out about him through word of mouth), being wary of the treatment because it isn’t explained to them, or — what Sumrok hears a lot — being judged or talked down to instead of given understanding and respect.

“In Shelby County, people complain about barriers to care, which many people think is because of economics,” she says. “But it may not be just economics that is keeping people from accessing treatment; it may be more about being judged, and not knowing what the treatment looks like.”

Being treated with respect builds trust, trust builds health

One of Sumrok’s patients – I’ll call him John, which is not his real name – has been driving 140 miles from Southeast Missouri to see Sumrok for the last five years. He began using drugs off and on during his 20s. When he was in his 30s, he injured his back, was sent to a worker’s comp physician, who prescribed stronger doses of pain killers until his back stopped hurting.

“I was taking pain pills like candy,” says the 46-year-old, who is married and has a son. “All of a sudden, the pills are gone, and you’re very sick, and I start looking for them everywhere – on the street, taking them from family members without asking – just to keep me from getting sick. I thought I had to have them to function. If I didn’t have six or seven pain pills, I wasn’t going to be able to get out of bed. If I didn’t get them, I’d be sick, puking… I’d do almost anything to have those pills.”

After he spent his and his wife’s life savings, and the money they’d put away to buy a home, and his retirement fund from a previous job; after he saw friends die from overdosing; and after he realized that he was risking losing his wife and son, he told his wife he needed help, and they found Sumrok.

“It’s been a miracle, for sure,” says John. As the Suboxone took effect, “after two or three weeks, I began to feel normal again.”

About two years ago, Sumrok asked him to fill out the ACE survey. “It really did make a difference,” says John. He had never connected experiences in his childhood with using drugs as an adult.

“When I was just a baby,” recalls John, “my grandpa took me from my mother, and told my parents: ‘When you guys are stable, I’ll let you have him back.’ Up until I was 10 or 11, I called them ‘Mom’ and ‘Dad’.’” His older sisters were sent to live with his other set of grandparents. He didn’t live with his parents again until he was 15 years old. His sisters were adults and out on their own by then.

Until he did the ACE survey and talked with Sumrok about his childhood, it didn’t dawn on him that losing his mother, father and his sisters at a young age could have affected him in ways he didn’t realize. “I knew I was loved by my grandfather and grandmother, but being a young kid and seeing other kids going out with their parents was frustrating,” he says. “I lived with old people who never left the house, while my parents were out running around. I maybe thought my mom and dad didn’t care about me enough to change. I might have always felt like I wasn’t important enough to my mom and dad for them to change the way they were living and acting.”

But now he has a better understanding of what it was like to be a 19-year-old in the late 1960s and involved in the drug and party scene then, as his parents were. He understands them better, and why they weren’t able to care for him. He and his family members have “had our discussions,” says John. “My family life is a whole lot better. I didn’t have relationships with my parents or sisters. We only live seven miles apart, and I barely saw them twice a year, if that. But now I have my wife back. I’ve got my son back. And I see my parents and sisters all the time. We’re a tight-knit family.” He’s also able to hold a job, and is a reliable employee.

John sees Sumrok once a month now. He participates in group therapy, where they can safely talk about their ACE scores without having to get into specifics. He checks in with Sumrok, who renews his prescription.

“I like group therapy with Dr. Sumrok,” says John. “He talks to us with respect. We feel very comfortable with him. Dr. Sumrok never lies. I trust him fully. And he trusts me. It took five or six months to build that trust. The more I met with him, the more I realized that he was really concerned about me. He wants to help people. Let him train more doctors in the procedures he uses. You can’t treat people like they’re nobodies.”

A 29-year-old patient, who chose to be called “Mr. Big” since I’m not using his real name, has been seeing Sumrok for the last six months. He had been in a methadone treatment program, and found Sumrok after he couldn’t pay for treatment any longer. Sumrok was the only physician who would take his insurance. Mr. Big filled out the ACE survey in the waiting room, but reported his score as a two. Then Sumrok went through the survey with him, and Mr. Big’s score climbed to an 8.

“It does help me understand my addiction better,” says Mr. Big, who is a single father of two children, five and six years old. “For one, my trauma in my childhood was very dramatic. I thought everyone’s parents did what they were doing. I could see why I related to narcotics and stuff. It was the only place I had to turn. I started taking opiates when I was 11 or 12 years old. I was playing football, and broke my ankle. They gave me painkillers that made me feel like Superman. I couldn’t get enough, because I wasn’t feeling like Superman without it.”

The Suboxone helps him feel “normal — probably the way everybody else feels,” says Mr. Big. “Nothing I took ever gave me that feeling before. I’m a better person, father, and a better brother” to his sister, whom he convinced to also get help from Sumrok.

The first time he went for help, to a methadone clinic, he didn’t like it for two reasons: Methadone made him nod off or feel high, and the people at the clinic treated him as if he was a number, or just there for the drugs. “That’s just unprofessional, in my opinion,” he says. “Sumrok actually sits down and talks to you like a human being.”

Mr. Big wants to work with Sumrok to develop a 'game plan so that I can live without my medicine,' he says. He just wants to live a normal life. What does a normal life mean?

“It means that I’m home overnight with my children,” he says. “I don’t have to rob, lie, steal, or cheat to find drugs. I can fit in with society and not be high off my mind. I can wake up every day and do stuff. My children — they know Daddy’s not in bed sick any more. It’s wonderful. I’m wore out. I never knew that first grade and kindergarten had homework that was so complicated.”

With addictions and deaths on upswing, how to increase addiction docs?

Prescription and illicit opioids are the “main driver of drug overdose deaths,” according to the CDC, with 33,091 deaths in 2015. That’s four times more than 1999. And between 2014 and 2015, Tennessee saw a 13.8 percent increase in opioid deaths. More than 1,000 people died from opioid overdoses in 2014, and tens of thousands of people lead desperate lives, most of them unknowingly fueled by their childhood experiences. "Only 10% of these are getting the help they need," says Sumrok.

Dan Sumrok is just one doctor, in one part of the country. How can what he does be scaled up to thousands of physicians who can treat addiction — all types of addiction — successfully in all parts of the U.S.? By doing what Dr. David Stern, Robert Kaplan executive dean and vice-chancellor for clinical affairs for the University of Tennessee’s College of Medicine and the University of Tennessee Health Sciences Center, did: launch the Center for Addiction Science.

“This really starts with Dr. Altha Stewart, who’s the director of the Center for Health in Justice-Involved Youth,” says Stern. “She’s the one who showed me that kids with high ACE scores end up in trouble. When I developed the Center for Addiction Science, it had to be like a cancer center, it had to be multi-disciplinary. In the old days, we thought people who had addictions were weak in the moral department. You really needed someone to straighten you out, because your mother didn’t do a good enough job.”

But that approach doesn’t work. Neither does criminalizing addictions. "Stigma drives problems underground," says Stern, "instead of driving them to a solution." The center is taking an integrated approach to using research and education to help people in all possible ways, from physiology to genetics to counseling.

Stern believes that every physician should know about ACE science, which is one of the reasons he chose Sumrok to lead the center, along with his willingness to be creative and seek solutions across disciplines. “Two of the most prevalent things in acute care are depression and addiction,” says Stern. “I think it’s important to be able to understand what ACE mean to patients, what addiction is all about, how to recognize it, how to treat it.” He’s in the process of finding an associate dean for medical education, and is looking for someone who will integrate ACE and other social determinants of health into the school’s curriculum.

“I think a medical school should provide for the community it serves,” says Stern. “This medical school should be the medical school for Memphis. We should develop solutions that are scalable.”

Dr. Altha Stewart, associate professor of psychiatry in the University of Tennessee College of Medicine, learned about ACE in 2009 when a group in Shelby County began educating people about ACE science. They brought Dr. Vincent Felitti, co-founder of the ACE Study, and Robin Karr Morse, who wrote Ghosts from the Nursery: Tracing the Roots of Violence, which was published in 2007, to give a presentation.

1-altha-stewart.jpeg

Dr. Altha Stewart

“It’s become a core part of what I do now in my professional work,” says Stewart, who was recently named president-elect of the American Psychiatric Association. She’s working with the Shelby County community and the local criminal justice system to integrate trauma-informed and resilience-building practices to find ways to help youth who enter the justice system — all of whom have likely experienced ACE — instead of shaming, blaming or punishing them.

The things that have happened to kids — as well as to many people who come into the health care system — are out of their control, says Stewart. “When you’re a child, you don’t control the people who abuse and assault you, who create hostile environments, who don’t provide you with clean clothes,” she says. “If a child can’t control their environment, because of these things they grow up thinking they’re bad, different, horrible people. This new approach (integrating trauma-informed and resilient-building practices based on ACE science) helps them feel like they’re not drowning anymore. When they can pop their head out of the water and get a breath, and see outstretched hands, a life preserver, a life boat, that changes their entire perspective.”

"When Sumrok began integrating ACE into addiction treatment, that was innovative,"
says Stewart. “If you don’t ask these questions, people tend not to tell you,” she says. Sumrok’s approach is part of a shift in patient engagement and involvement. “The trend in health care is that patients are partners in their treatment.”

"This new knowledge about why and how humans behave the way they do also speaks to how we have trained the medical profession,”
says Stewart. "The traditional approach is that physicians “know everything. The people whom we treat know nothing. We tell them what to do, and if they don’t get better or do what we say, it’s their own fault."

“That’s simply not true,”
she emphasizes. “Some of us have come to understand that there’s more expertise in the community and our patients than we’ve understood. That takes a bit of humility on the part of a physician, and an understanding that we are partners in helping a person heal.”

Sumrok’s experience with the young fellows at the Center for Addiction Science is giving him some real hope that the medical profession can change. When he’s explained to them how important it is to ask patients about ACE and other aspects of their lives — such as food availability, safe housing, transportation, jobs (in the medical profession vernacular: social determinants of health) — “they say ‘isn’t that just taking a patient history?’”

He and others at the University of Tennessee Health Sciences Center have an opportunity to educate young physicians outside the state, too. Derefinko is also director of the newly created National Center for Research of the Addiction Medicine Foundation. The foundation oversees the 130 addiction medicine fellowships at 46 medical schools across the country.

“We want metrics to understand the impact they’re having when they go out in the world," says Derefinko: "where they go, whom they’re treating, how they’re practicing, whether they’re integrating ACE science. In addition, the foundation will be developing some accreditation guidelines, so that all fellows receive the latest and best education in addiction medicine."

"One of those elements,"
says Sumrok, "has to be empathy, which physicians can practice by listening, acknowledging and understanding how the experiences in a person’s childhood and adulthood have shaped their lives and health."

“Can you teach empathy?”
he asks. “Can people learn to be empathetic providers? I think you can. I think so.”

*From the article here :
 
I don't understand my trauma fully but it wasn't nearly as bad as others so not sure that is what drives my issues entirely but maybe
 
Top